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Background and objectives 
South Africa is characterised by colliding epidemics of non-communicable and
communicable diseases. Additionally, the prevalence of stunting, which affects almost a third 
of children under-five, has remained unchanged over the past decade. Regarding 
communicable diseases, infection with Human Immunodeficiency Virus (HIV) is endemic as
South Africa is home to 1 in 5 people living with HIV globally, and approximately one
in three pregnant women is HIV positive. Despite this, the success of the Prevention of
the Mother to Child HIV Transmission (PMTCT) programme, particularly in the 
era of widespread use of triple antiretroviral treatment (ART) for PMTCT and
maintenance of maternal health, has made it possible for most HIV-exposed children to
remain uninfected. Thishas led to an emergence of a large population of HIV exposed 
uninfected (HEU) children for whom there are limited data on health outcomes.
Notwithstanding the benefits of ART for PMTCT, in-utero exposure to ART may have
risks that require further investigation. The significance of various postnatal growth
velocities also needs further exploration as it is a research area that is not well understood
and international growth velocity standards were not available prior to 2009. Thus very few 
studies have applied these standards.
Given this background, this thesis sought to describe child growth and its determinants in 
South Africa, a country with high malnutrition and HIV prevalences, under different 
PMTCT policies between 2002 and 2013, using the latest WHO growth standards. 
Specifically the thesis aimed to assess the effect of early infant feeding practices on 
growth velocity in the first 6 months, and the effect of both on body mass index-for-age-age
Z-score (BMI-for-age Z-score) at 2 years of age (Paper I); to compare the longitudinal 
growth of HIV-exposed and -unexposed children in South Africa using the WHO growth 
velocity standards (Paper II) and to study the effect of infant in-utero HIV and ART 
exposure on preterm delivery (PTD), low birth weight (LBW) and small-for-gestational age
(SGA) at birth, and underweight-for-age (UFA) at six weeks postpartum in children 
attending primary health care facilities in 
9
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South Africa during established implementation of WHO PMTCT Option A policy (Paper
III). 
Methods
Data from 3 studies conducted in South Africa were utilised. For Paper I HIV-negative 
women were recruited in pregnancy and followed-up at 3, 6, 12 and 24 weeks and 2 years 
postpartum with their children. For Paper II, the majority of the HIV-positive and -
negative women were also recruited antenatally, with only a few recruited postnatally while 
still in hospital, and followed up with their children at 3, 24 and 36 weeks postpartum. 
For Paper III, data from a cross-sectional survey of HIV-exposed and -unexposed
children attending their 6-week immunisation clinic visit were utilised.  
Exposures
Only self-reported HIV-negative women and their children were considered in Paper I. The 
main exposures in this paper were infant feeding practices and growth velocity in the first few 
months of life. The child’s HIV infection and exposure status, and the additional antiretroviral 
drug exposure status for children born to HIV-positive mothers, were the main exposures in 
Papers II and III. In these papers the child’s HIV infection status was ascertained by the 
polymerase chain reaction test (PCR) using dried blood spot specimens obtained from the 
children by trained data collectors. In each primary study questionnaires were used to also 
collect information on key factors related to child health from mothers/caregivers, including 
child feeding practices established through 24-hour and seven-day recall questions.  
Outcomes
Child weights and recumbent lengths/standing heights were measured by well-trained data 
collectors in Papers I and II and extracted from the patient-held road to health booklets in 
Paper III. Birthweights and gestational ages (based on fundal height and/or last menstrual 
period) were extracted from the road to health booklets in all three studies. Anthropometric 
10
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scoring was done using the 2006 WHO attained growth standards (used to estimate weight-
for-age Z-scores (WAZ), length-for-age Z-scores (LAZ), weight-for-length Z-scores (WLZ) 
and body mass index(BMI)-for-age Z-score), 2009 WHO growth velocity standards (used to 
estimate weight and length velocity Z-scores (WVZ and LVZ respectively)) and recent 
Intergrowth-21st standards for assessing new born size for term and preterm infants (used to 
estimate birthweight-for-gestational-age Z-scores). Birth outcomes included low birth weight
(LBW), preterm delivery (PTD) and small-for-gestational age (SGA).
Analysis 
Simultaneous quantile regression was used to assess the effect of 1) early infant feeding 
practices on growth velocity in the first 6 months, and 2) both on BMI-for-age Z-score at 2 
years of age in Paper I. Mixed effect regression was used to compare the mean growth velocity 
Z-scores of HIV-exposed and -unexposed children in Paper II. Logistic regression was used
to study the effect of in-utero HIV and ART exposure on PTD, LBW and SGA at birth, and
UFA at six weeks postpartum in Paper III.
Results 
Paper I demonstrated that children who were not breastfed at 12 weeks had higher mean WVZ 
between 12 and 24 weeks, higher BMI-for-age Z-scores at 2 years and were more likely to be 
overweight or obese. Although most of the children were initiated on breastmilk early, the 
proportion of breastfed children decreased in the first 12 weeks of life while the frequency of 
formula feeding increased. The early introduction of solids such as cereals was also common. 
Paper II demonstrated that HIV-infected children were not only more underweight, wasted 
and stunted compared to HEU and HIV unexposed uninfected (HUU) children, but also had 
poorer growth velocity in the first few of months. The data also showed that maternal viral 
load, LBW and Nevirapine use were independent influencers of growth velocity in HIV-
exposed children and that HIV-positive children had increased infectious morbidity compared 
to HUU children. Paper II also demonstrated that HEU children had similar attained growth 
and growth velocities compared to HUU children in the absence of maternal ART. Unlike in 
Paper II, data from Paper III demonstrated that HEU children had poorer birth and early 
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attained growth outcomes than HUU children. The results in Paper III also demonstrated that 
HEU children born to women with unmanaged HIV infection had an increased odds of being 
born preterm than children born to women on ART, and that children whose mothers initiated 
ART before conception had an increased odds of PTD than children whose mothers started 
ART after conception, but no increased odds for other outcomes.  
Conclusion 
This thesis highlights the importance of not only addressing the double burden of malnutrition 
in South Africa, but also the burden of colliding disease epidemic of communicable and non-
communicable diseases. The strong association observed between infant HIV infection and 
poor growth highlights the importance of addressing the unfinished agenda of combating the 
HIV epidemic. While early initiation of HIV-positive women on ART is important for 
preventing MTCT and maintenance of maternal health, data does signal that pre-conception
ART initiation may have an adverse effect on PTD. As access to ART increases routine 
surveillance system should be set up to monitor adverse outcomes. The emergence of a large 
population of HEU for whom there are limited data also warrants the urgent need for the close 
follow-up, through surveillance systems and in-depth cohort studies, of this sub-population 
of children. There is also an urgent need to tackle persistent undernutrition in both HIV-
exposed and -unexposed South African children while curbing the concomitant rise of 
overnutrition, possibly thorough facility and community based support programmes. 
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Chapter 1: Background 
The aim of this chapter is twofold. Firstly to define key terms and secondly to provide an
overview of literature used to establish a theoretical framework for the research topic under 
study. To achieve this aim the chapter begins with a definition of malnutrition followed by a 
description of methods used to assess malnutrition and then an overview of the global and 
regional extent of child malnutrition. Given that HIV and inadequate feeding practices are 
risk factors for malnutrition, especially in low and middle-income countries (LMIC), the 
thesis then reviews literature on HIV and infant feeding practices.
1.1 Malnutrition
Malnutrition is defined as “an abnormal physiological condition caused by inadequate, 
unbalanced or excessive consumption of macronutrients and/or micronutrients. Malnutrition 
includes undernutrition and overnutrition as well as micronutrient deficiencies” (FAO. et al., 
2015). Furthermore, malnutrition can also occur as a result of poor absorption or metabolism 
of nutrients or increased demand for nutrients as occurs during infection  
1.1.1 The assessment of malnutrition 
Malnutrition in an individual or population can be assessed using various approaches 
including biochemical, clinical, dietary history/ assessment (including duration and pattern of 
feeding) and anthropometrical methods (Norgan et al., 2012). For example a child with a 
WLZ<-3 would be regarded as severely malnourished in accordance with anthropometry; one 
clinical manifestation of this condition would be bilateral oedema (World Health 
Organization and UNICEF, 2009). Dietary assessments and anthropometry were considered 
in this thesis and are thus reviewed here. 
Dietary assessment
One of the objectives of this thesis was to assess the effect of feeding on child growth. This 
necessitated a review of literature on infant feeding recommendations and definitions and
dietary assessment methods. Human breast milk has sufficient energy and nutrients (including 
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protein, fats, vitamins and minerals) to support the growth and development of children in the 
first few months of life. It is estimated that 850ml/day of breast milk intake can meet the 
energy requirements of an infant growing along the 50th centile of the NCHS reference for 4
months. For children born in low-middle income country settings, who are generally born 
smaller than children in high income countries such as the United States, the intake would be 
adequate for 6 months if the infant was growing along the 25th centile (Whitehead and Paul, 
2000). Prior to 2001 the World Health Organization (WHO) recommended exclusive 
breastfeeding (EBF) for 4-6 months followed by the introduction of complementary foods at 
6 months and continued breastfeeding until 2 years (World Health Organization, 1995b). In 
2001 the WHO recommended that the EBF period be extended to 6 months (World Health 
Organization, 2002a, World Health Organization, 2003), based on evidence from LMICs 
(Belarus, Iran and Nigeria) that demonstrated that EBF for 6 compared to 4 months is more 
protective against infectious disease morbidity and mortality in these settings (World Health 
Organization, 2002b, World Health Organization, 2002a, World Health Organization, 2003). 
Based on the known risk of vertical HIV transmission in the absence of ARV drug
interventions (De Cock et al., 2000), the WHO also published separate infant feeding 
guidelines for HIV-positive women (World Health Organization, 2006a) and these are 
discussed later in this chapter. In 2008, following changes in the infant feeding 
recommendations, revised global guidelines for infant feeding indicators were also published 
and were the basis for the EBF, predominant breastfeeding (PBF) and ever breastfed 
indicators that were used in this thesis (World Health Organization, 2008a). A number of 
dietary assessment methods are used to collect dietary data for the construction of the feeding 
indicators. These include the use of dietary records (such as food diaries), food frequency 
questionnaires and dietary recall questionnaires  that are used to assist the mother/caregiver
recall foods/liquids the child had consumed in the preceding day or week (Thompson and 
Byers, 1994). 
Anthropometric assessment 
Physical “growth”, is defined  as a quantitative increase in cell number (due to cell division) 
or cell mass (due to an increase in cellular substance) (Himes, 2004). Poor physical growth in
Vundli Ramokolo
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children is one of the first visible signs of malnutrition (Ruel-Bergeron et al., 2015).
Anthropometry compares the physical growth measurements of the child against those of a 
reference population to assess the growth rates or nutritional status of the child (World Health 
Organization, 1995a). However, anthropometric measurements have a limited diagnostic 
property, and therefore micronutrient deficiency can exist irrespectively of anthropometric 
status. 
Growth measurements 
The most commonly used measurements in children include weight, length or height, head 
and mid-upper arm circumference (MUAC). When performed at a given time point these 
measurements quantify attained size or mass at that particular time. This provides information 
on cumulative historical changes in the body size and mass (Himes, 2004). The individual 
human growth curves in Figure 1 illustrate the difference between the distance curve (which 
represents the height the child attained from birth until 18 years), the velocity growth curve 
(the rate of change in height expressed in units per time period) and the acceleration curve 
(the change in velocity through time) (Molinari and Gasser, 2004)
Figure 1: The relationship between the distance and velocity curves. Reproduced from (Molinari and 
Gasser, 2004) with permission from Cambridge University Press.
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As child growth varies by sex and age anthropometric measurements need to be standardized 
for these characteristics. One approach is to convert these measurement values into 
anthropometric indices. The most commonly used anthropometric indicator in children is 
weight-for-age because of the relative ease of obtaining weight measurements. However, this 
indicator does not distinguish between children that are stunted (a measure of chronic 
undernutrition) and wasted (a measure of acute undernutrition). Height is therefore measured 
in addition to weight so height-for-age and weight-for-height can be calculated, and if the
values of these indicators are low the child is regarded as stunted and wasted respectively. 
The use of the body mass index (BMI)-for-age, which is a ratio of weight (in kilograms) 
divided by recumbent length or standing height (in meters squared), indicator to screen for 
overweight/obesity in children is also becoming increasingly important given the rise in the 
circular trend of childhood overweight (World Health Organization, 2006b). 
Anthropometric scoring 
Given that malnutrition is a clinical syndrome with several phenotypes (for example stunting, 
wasting or obesity), it can be detected by scoring a child’s anthropometric measurements 
within a distribution of values from a sample of children of the same age and sex. The scoring
is generally used for three purposes: screening, surveillance or monitoring. Screening is 
commonly conducted at a community level to identify children with a disease risk. This 
activity is performed cross-sectionally using simple-to-use yet precise instruments with the 
purpose of referring identified children for further investigation or therapeutic assistance. For 
example, the MUAC tape is used by community health workers to identify children, aged 6-
60 months, with severe acute malnutrition (SAM) in community settings. Children with 
MUAC measurements below 115mm are either referred for further assessment and treatment 
at a health facility or are managed at the community-level using Ready-to-Use-Therapeutic-
Foods (RUTF). After treatment initiation repeat anthropometric measurements can be taken 
from the sample of malnourished children for surveillance purposes, i.e. to assess the group-
level treatment effect on growth. Surveillance may identify an individual child requiring more 




The position of a measurement within the distribution can be expressed using three 
classification systems: standard deviation scores (Z-scores), percentiles or percent-of-median.
The Z-score system has the following characteristics that make it more agreeable to use than 
the other approaches: 1) for normally distributed measurements the Z-scores can be expressed
as means and standard deviations to describe the group-level nutritional status or growth rates
and 2) Z-scores can be used to assess longitudinal growth and 3) as the Z-score distribution 
is on a linear scale from - , changes in Z-scores at the extremes of the distribution can 
be quantified. Although percentiles are easier to interpret in clinical practice they are less
preferred in research because they are calculated on the rank scale that ranges from 0 to 100.
This feature makes it difficult to quantify changes in percentiles at the extremes of distribution
(Wang and Chen, 2012). The percent-of-median can also be used to describe non-normally 
distributed data and is easier to estimate than Z-scores and percentiles. One major 
disadvantage of using this system is that the estimation of the percent-of median does not take 
the distribution of the reference population into account therefore the interpretation of the 
estimate changes in accordance with the age of the child (Gorstein et al., 1994). The Z-score 
system was used in this thesis, and is defined as the number of standard deviations below or 
above the mean as seen in Equation 1, where  denotes the Z-score, the measurement value, 
the mean of the measurement values and the standard deviation of the measurement values
(World Health Organization, 1995a). 
= [Equation 1] 
The lambda-mu-sigma (LMS) model values are added in the Z-score estimation to 1) allow 
and to change with age so that the Z-score is standardized for the child’s age and 2) account 
for any skewness in the distribution of the measurement values, such as those for weight (Cole 
and Green, 1992), see Equation 2:  
= [( )( ) ] ( )( ) ( ) [Equation 2]
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In this equation lambda ( ) is the Box-Cox power that transforms skew measurement values 
to a normal distribution, mu ( ) is the mean, sigma ( ) is the coefficient of variation (ratio 
of standard deviation to the mean), t is the child’s age and y the measurement value (absolute 
value for attained Z-score and increment for velocity Z-score). When =1 the standard 
deviation of is equal to the coefficient of variation of y. For weight velocity Z-score 
calculations a constant, delta ( ), is added to the weight increments to ensure their values are 
above zero (Cole and Green, 1992, World Health Organization, 2009b). In this thesis, as in 
many research studies, external rather than internal Z-scores were computed using LMS 
values from growth standards.  
Growth references and standards 
The classification of a child as malnourished requires the clinician or researcher to compare 
the anthropometric values of the child against those of a child of the same age and sex in a 
growth reference or standard. The fundamental difference between growth references and 
standards is that the former is a descriptive distribution of anthropometric measurements 
taken from a group of children in a particular geographical region and time while the latter is 
a prescriptive set of standards that describes how children should grow under optimal 
conditions (de Onis et al., 2006). Examples of a growth reference include the 1977 National 
Centre for Health Statistics (NCHS) which has been used to analyse growth in several African 
studies (Bakaki P., 2001, Bobat et al., 2001, Isanaka et al., 2009, Lepage et al., 1996).
However these references were inappropriate for assessing the growth of non-US based child 
populations, particularly those that are breastfed in the first few months of life (de Onis et al., 
2007), highlighting the need for an international growth chart such as the 2006 WHO growth 
standard (de Onis et al., 2007, World Health Organization, 2009a).  
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WHO attained growth international standards 
In 1997, WHO initiated the Multiple Growth Reference Study (MGRS) to collect growth data 
from children living in diverse settings using stringent inclusion criteria. Data collection took 
place between July 1997 and December 2003 in six countries (Brazil, Ghana, India, Norway, 
Oman and USA) so as to make the growth standards relevant for children living in different 
contexts worldwide. As a growth standard is a prescriptive distribution of how healthy 
children should grow when living in optimal conditions, only healthy children born to non-
smoking mothers living in socio economic conditions that did not constrain growth and who 
were exclusively or predominantly breastfed for at least four months, were introduced to 
complementary foods by 6 months  and were still breastfeeding at 12 months, were included 
in the study (de Onis et al., 2004). The WHO child growth standards were released in April 
2006 and are available for weight, length/height and BMI (World Health Organization, 
2006b). 
WHO growth velocity international standards
In addition to the standards for attained growth, in 2009 the WHO also published prescriptive 
international standards for growth velocity , which is the rate of growth (Tanner, 1990), that 
made it possible to compare the growth rates of their study children against those of a sample 
of relatively healthy predominantly breastfed children (World Health Organization, 2009b).  
Growth velocity standards are used to assess the rate of growth over a period of time so they 
measure growth rather than attained status. WHO growth velocity standards were 
develop  from the longitudinal (birth till 24 months) data collected in the MGRS study. 
Weight and length measurements were taken at the following intervals: birth; 1, 2, 4, 6, and 
8 weeks; and 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 16, 18, 20, 22, and 24 months. The WHO 
growth velocity curves are therefore appropriate for assessing the rapidly changing rate of 
growth in children in the first two years of life. These prescriptive growth velocity standards 
were published for velocity of weight, length and head circumference over various intervals 
(World Health Organization, 2009a) and have not been extensively applied yet.
22
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Tanner (1978) suggests that using growth velocity, a measure of current rate of growth, to 
assess child growth would enable one to detect growth faltering earlier than if one were to use 
attained growth for age which assesses cumulative growth. The foetus develops in the uterus 
of the mother in a system, known as the feto-placental unit, which adapts to stimuli. These 
intrauterine growth adaptations often lead to catch-up or catch-down growth in the first six 
months of the postnatal period. Genetic, physiological and environmental factors also 
contribute towards the varying growth rates, characterised by periods of rapid and slow 
growth, observed in individual children in the postnatal period. Successive periods of 
consistently high or low growth velocity can be an indication that the infant is at risk of a 
disease or is diseased.  
Intergrowth-21st standards for foetal and newborn growth 
Similar to the WHO standards, the Intergrowth-21st international standards for newborn 
weight, length, and head circumference by gestational age and sex were generated using data 
from exclusively/predominantly breastfed infants from several countries (Brazil, Italy, Oman, 
UK, USA, China, India and Kenya) so they can be applied in different settings. These 
standards are prescriptive and can be used to assess foetal and infant growth for term and pre-
term infants (Villar et al., 2014). Conceptually they are therefore an extension of the WHO 
standards which were constructed using data from term-born infants. 
Cut-off points and definitions 
Cut-off points for anthropometric indicators can be established using risk-based and statistical 
methods. The most commonly used statistically defined cut-off points of -2 and -3, which
define moderate and severe undernutrition respectively, are arbitrary as in reality children that 
fall below these cut-off points are often a combination of physiologically undernourished and 
healthy children (Pelletier, 2006). A low weight-for-length Z-score (WLZ) or WHZ denotes 
that the child is wasted, a measure of acute malnutrition probably due to a sudden loss of 
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weight or a failure to gain weight as commonly seen in children with diarrhoeal episodes.
Historically, wasting has been referred to as protein energy malnutrition (PEM), kwashiorkor 
(children with low WHZ or MUAC with oedema) or marasmus (children with wasting 
without oedema) (Lenters et al., 2016). These definitions have now been replaced with the
term “severe acute malnutrition (SAM)”, which defines children with WHZ<-3 or 
MUAC<115mm or bilateral oedema (World Health Organization, 2013b). Another term, 
“moderate acute malnutrition (MAM)”, defines children with WHZ between -2 and -3 or 
MUAC 115mm to <125mm (World Health Organization, 2012a). A low length-for-age or 
height-for-age Z-score (LAZ or HAZ respectively) indicates that the child is stunted and is a 
measure of chronic undernutrition. A low weight-for-age Z-score (WAZ) indicates that the 
child is underweight for age (UFA) but does not distinguish between a wasted (tall thin child)
and stunted (short child with an appropriate weight) child (Gorstein et al., 1994). As BMI 
changes with age in childhood and also differs between boys and girls, the BMI classification 
in children needs to take into account both the age and sex of the child (Dinsdale et al., 2011).
Children under-five with BMI-for-age Z-score +1 are defined as “at risk for overweight”, 
while those with BMI-for-age Z-score +2 and +3 are overweight and obese respectively
(World Health Organization, 2008b).  
For perinatal outcomes universally recognised cut-off points are used to define low birth 
weight (LBW) as birthweight below 2.5kg, preterm birth delivery (PTD) as birth before 37 
completed weeks of gestation and small-for-gestational age (SGA) as birth-weight-for 
gestational-age Z-score below -1.28, which is equivalent to the 10th percentile (World Health 
Organization, 1977). 
1.1.2 The global burden of under-and over-nutrition in children 
Although the global number of undernourished people has decreased since the early 1990’s, 
795 million people still experience hunger (FAO. et al., 2015). It is for this reason that the 
second Sustainable Development Goal (SDG) is to ‘end hunger, achieve food security and 
improved nutrition and promote sustainable agriculture’ by 2030 (UNDESA, 2015).While 
global estimates of childhood undernutrition are showing a downward trend, progress towards 
achieving the World Health Assembly (WHA) goals of reducing stunting by 40% and wasting 
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to less than 5% by 2025 has been slow. Although the global prevalence of stunting declined
from 32.7% in 2000 to 22.9% in 2016, 155 million children in the world are still stunted.
Globally, MAM and SAM affected 7.7% (52 million) and 2.5% (17 million) of children 
under-five respectively in 2016. The global prevalence of childhood overweight increased
from 5.0% in 2000 to 6.0% (41 million children) in 2016 and is still on the rise (UNICEF et 
al., 2017). Consequently more efforts are also required to reach the WHA goal of halting the 
increase in childhood overweight by 2025.
1.1.3 Double burden of malnutrition in Africa 
Progress towards reducing malnutrition has been uneven, with regions such as Africa lagging 
behind. Africa, particularly sub-Saharan Africa, has some of the highest prevalences of 
stunting, underweight and wasting in children under-five in the world (Black et al., 2013). In 
2016, the prevalences of stunting, wasting and overweight were 59%, 14% and 9.8% 
respectively in Africa. This region was not only home to more than a third (38%) of all stunted 
children globally but also the only region that experienced an increase in the absolute number 
of stunted children since 2000, largely due to the rise in stunting and population growth in 
Western Africa. In addition, almost a third (27%) of the world’s wasted children lived in 
Africa in 2016. This region also has a high burden of overnutrition, and was home to almost 
a quarter (24%) of the world’s overweight children in 2016 (UNICEF et al., 2017). In South 
Africa stunting in children persists with the latest estimates demonstrating that 27% children 
under-five are stunted while 3% are wasted. There is also a concomitant rise in overnutrition 
with the prevalence of childhood overweight estimated at 13% (National Department of 
Health et al., 2017).  
These data suggest that both under- and over-nutrition often co-exist not just in high income 
countries, but also in LMICs, as they have common risk factors and etiological pathways that 
give rise to the double burden of malnutrition. 
1.1.4 The developmental origins of malnutrition 
As the growth and development of the foetus is influenced by, amongst others genetic and 
epigenetic factors, malnutrition can start in-utero and even pre-conception. It is estimated that 
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15-20% of children are born LBW each year globally. In Sub-Saharan Africa the incidence
of LBW is approximately 13% (UNICEF, 2016, World Health Organization, 2012b). LBW
can result from PTD and/or if an infant is born SGA (Kramer, 2013), both of which are
important risk factors for childhood undernutrition in LMICs (Christian et al., 2013, Danaei
et al., 2016). In addition, complications from PTD are a significant public health concern as
they account for 28% of neonatal deaths globally (Lawn et al., 2005), and are the leading
cause of neonatal deaths in South Africa (Msemburi et al., 2016).
Undernutrition in early life can also alter immune function and predispose children to the 
later-onset of non-communicable diseases (NCDs) and premature death. One of the first 
studies to explore this phenomenon reported a positive correlation between arteriosclerotic 
heart disease related adult mortality rates in Norway in 1964-1967, and the infant mortality 
rates in the same sample decades earlier (1896-1925) (Forsdahl, 1977). Similarly Barker and 
Osmond (1986) reported a correlation between infant mortality in 1921-1925 in England and 
Wales and coronary heart disease related adult mortality in the same regions 70 years later 
(1968-1978). These ecological observations were the precursors to numerous studies that 
have since showed that children born LBW, a proxy for poor foetal growth, are more likely 
to die from NCDs such as coronary heart disease , hypertension (Eriksson et al., 2007), stroke 
(Martyn et al., 1996) and type 2 diabetes (Barker, 1999) in adulthood. Undernutrition during 
critical intrauterine periods, characterised by rapid cell division and sensitivity to 
environmental stimuli, may lead to permanent changes in the structure and function of organs,
alterations in hormone secretion and metabolism and changes in body size that lead to smaller 
or physiologically disproportioned children at birth (Barker, 2012). In accordance with the 
“thrifty phenotype” hypothesis, such changes in the foetus lead to a higher risk of developing 
NCDs in adulthood particularly if the infant experiences overnutrition in the postnatal
environment (Barker and Lampl, 2013, Hales and Barker, 2001). This concept is illustrated 
in Figure 2, where we see that a LBW baby with limited access to good nutrition can develop 
into a stunted adolescent girl and if she consumes a calorie-dense diet later in life she can 
become an overweight or obese woman. Figure 2 is however incomplete as the overweight or 
obese woman can in turn give birth to a large baby.
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Figure 2: The double burden of malnutrition: causes and effects across the life course. Reproduced
from (Shrimpton and Rokx, 2012) with permission from The World Bank. 
Brenner and colleagues further hypothesized that poor foetal growth may lead to a reduction 
in cell numbers in the kidneys, which are prioritised less in-utero compared to organs such as 
the brain, thereby leading to the later development of hypertension and kidney disease
(Brenner et al., 1988, Luyckx and Brenner, 2015). NCDs, including lung disease and cancer, 
are a major public health concern as they a  long-term burden on the health 
system, communities and affected households. In 2014 NCDs accounted for 16 million 
premature deaths in adults globally. The majority (82%) of these deaths occurred in LMIC. 
The situation in South Africa is also dire as it is estimated that adults aged between 30 and 
70 years had a 27% probability of premature death from cardiovascular disease, cancer, 
diabetes or chronic respiratory disease in 2012 (World Health Organization, 2014b). The 
consequences of poor foetal growth can therefore be far-reaching across the life-span; it is 
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1.1.5 The multifactorial nature of malnutrition
Malnutrition is a complex phenomenon with numerous risk factors operating at different 
levels (Figure 3). Although Figure 3 describes the main causes of undernutrition some of these 
risk factors also apply to overnutrition. At the immediate level are the individual causes of 
malnutrition and they include decreased intake of nutrients, poor absorption or metabolism of 
nutrients and increased demand for nutrients as occurs during infection. 
1.1.6 Malnutrition and immune dysfunction 
Malnutrition and infection are closely linked. When they exist in a synergistic relationship 
infection worsens malnutrition while, on the other hand, malnutrition increases the risk of
infection and compromises the ability of the infected individual to fight infection. In such 
instances the combined effect of malnutrition and infection is more intense compared to the 
sum of the effects of malnutrition and infection alone (Scrimshaw et al., 1968). The 
development of the immune system is sensitive to nutritional cues, particularly in the first 
1000 days of life (Bourke et al., 2016). In children severe undernutrition and various 
micronutrient deficiencies interfere with several immune defence mechanisms, such as 
antibody production and cell mediated immunity (Scrimshaw and SanGiovanni, 1997), thus 
increasing susceptibility to infections. As exemplified by diabetics who are prone to diabetic 
foot infections caused by pathogens such Staphylococcus aureus and Pseudomonas 
aeruginosa, overnutrition and related NCDs can also increase the risk of infection (Schaible 
and Kaufmann, 2007). Infections can lead to or worsen malnutrition by lowering the 
availability of nutrients, as seen in children that develop environmental enteropathy—a
condition characterised by an impairment of the integrity and function of the small intestine 
through villous atrophy, increased permeability, inflammation and poor absorption of 
nutrients (Bourke et al., 2016, Humphrey, 2009). Infections may also lead to undernutrition 
by stimulating immune responses that require additional energy or by inducing a loss of 


































































































1.2 HIV in South Africa
1.2.1 35 years of HIV and AIDS: policy development and outcomes 
HIV/AIDS remains a global health problem, with 1.9 million new HIV infections reported in 
adults in 2015 and less than half (38%) of people living with HIV (PLHIV) virally suppressed
(UNAIDS, 2016b). South Africa is home to 1 in 5 of PLHIV globally (South African National 
AIDS Council and National Department of Health, 2017) and has thus the highest number of 
people living with HIV/AIDS for a single country, estimated at 7.1 million in 2015. Further, 
it has the largest antiretroviral therapy (ART) programme in the world with approximately 
3.7 million HIV-positive adults on ART (UNAIDS, 2016a).   
The first cases of acquired immunodeficiency virus syndrome (AIDS) in South Africa were 
reported in two homosexual men in 1982 (Ras et al., 1983). By the early 1990’s the HIV 
epidemic was rapidly increasing in the general population and mother to child HIV 
transmission (MTCT) from infected pregnant and breastfeeding women to their children was 
becoming a huge concern. Without any intervention, in breastfeeding populations, up to 45% 
of HIV-exposed children can be infected with HIV (De Cock et al., 2000). As transmission 
can take place in-utero, during labour and delivery or via breastfeeding, the prevention of 
mother to child transmission of HIV (PMTCT) programme involves interventions that target 
primary prevention in women of reproductive age, preventing unwanted and unintended 
pregnancy in HIV-positive women, reducing MTCT during pregnancy, delivery and 
breastfeeding and care and treatment of the mother and family (Luzuriaga and Mofenson, 
2016). The early years (up to 2002) of the South African PMTCT and ART programme were 
marked with controversy around the government’s reluctance to provide antiretroviral (ARV) 
drugs to infected people because of safety and affordability concerns. Once the Medicines 
Control Council (MCC) of South African had assessed the safety of Nevirapine (NVP) and 
registered the drug the government piloted the PMTCT programme in 18 purposively selected
sites (two from each of the nine provinces) during 2000-2001. The PMTCT policy at the time
recommended voluntary counselling and testing, NVP to HIV-positive mothers during labour 
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and to their infant during the first 72 hours of life, infant feeding counselling and free 
provision of commercial infant formula to avoid HIV transmission through breastfeeding 
(Burton et al., 2015). This programme was scaled-up nationally between 2002 and 2007 by 
order of the Constitutional Court (Abdool Karim et al., 2009). It has since evolved from 
providing i) Zidovudine (ZDV) prophylaxis or triple antiretroviral treatment (ART) using 
criteria-based strategies that determine eligibility for ART (2008 and 2010 (WHO PMTCT 
‘Option A’) PMTCT guidelines); to ii) ART for all HIV-positive pregnant women throughout 
pregnancy and breastfeeding with ART cessation after the MTCT risk period ceases for those 
who do not need ART for their own health (‘Option B’ in the April 2013 guideline); to iii) 
‘Option B+’ in January 2015 which recommends lifelong ART (‘akin to ‘universal test and 
treat’) for all pregnant and lactating women irrespective of their CD4 cell count or 
clinical staging (Figure ). Notwithstanding such advancements in reducing MTCT there is 
emerging evidence that ART use in pregnancy could carry risks for the foetus, including
poor birth outcomes such as PTD (Jao and Abrams, 2014).  
1.2.2. The consequences of malnutrition and HIV infection: mortality 
In South Africa, the contribution of HIV/AIDS to deaths in children under-five and young 
adults (15-49 years) peaked in 2005 (47%), Figure 4. Following the scale-up in ART and 
PMTCT coverage and access (Johnson, 2012, Pillay et al., 2014), this has been sharply 
declining, contributing to 19% of under-five deaths in 2012 (Bradshaw et al., 2016). As the 
proportion of HIV/AIDS related under-five deaths has decreased in South Africa, other causes 
of child death have come to the fore (Figure 4). Vital registration mortality data for children 
under-five shows that the proportion of deaths directly caused by undernutrition, particularly
severe undernutrition, has remained fairly unchanged at around 4% since 2000 (Figure 4).
The impact of undernutrition on child mortality is however much greater as it is an underlying 
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1.3 HIV and infant feeding
The underlying causes of malnutrition include household food insecurity, unhealthy 
household environment, inadequate health services and inadequate infant care and feeding 
practices. It is now widely recognised that breastfeeding is the ideal infant feeding mode in
the first few months of life. Breastmilk not only has all the necessary nutrients to support 
optimal growth and development, but also has other advantages including antibodies to 
protect against common childhood infections such as those that cause diarrhoea. Additionally 
breastmilk is important for the maintenance of a normal microbiome that protects against 
dysbiosis which has been associated with allergies, auto-immune and chronic inflammatory 
conditions (Akre, 1989, Huang et al., 2017). This is particularly important in LMIC settings,
where access to amenities such as a refrigerator and a stove for storing and preparing 
replacement foods may be limited, and where replacement feeding may not be affordable and 
safe.
Although there is limited national data on infant feeding practices in South Africa, up until 
recently the available historical data showed that more than 80% of children were ever 
breastfed and less than 10% were EBF until 6 months by the early 2000s (National 
Department of Health et al., 1998, National Department of Health et al., 2003). Although the 
proportion of EBF children still shows a decreasing pattern with infant age, data from the 
2016 South African Demographic and Health Survey (SADHS) shows that the percentage of 
children that are EBF until 6 months increased from 8% in 2003 (National Department of 
Health, 2004) to 32% in 2016 (National Department of Health et al., 2017). The emergence 
of the HIV epidemic in South Africa further complicated infant feeding practices as ARVs 
were not widely available for all HIV-positive women in the 2000’s. As 15-20% of HIV-
exposed children could get infected through breastmilk in the absence of ARV drug
interventions (De Cock et al., 2000), in October 2000 WHO recommended avoidance of 
breastfeeding for HIV-positive women if replacement feeding was acceptable, feasible, 
affordable, sustainable and safe (AFASS). If the AFASS criteria could not be met then EBF
was recommended for the first 6 months of life and cessation of breastfeeding encouraged as 
soon as replacement feeding was AFASS to minimize MTCT risk. In 2006 the guidelines 
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were updated to include a recommendation that encouraged continued breastfeeding if 
replacement feeding was still not AFASS by 6 months postpartum (World Health 
Organization, 2006a). In line with these WHO recommendations the South African National 
Department of Health (NDoH), between 2001 and 2012, provided free commercial infant 
formula in public health facilities (Ijumba et al., 2013). Routine programme data from 2002 
shows that 67% and 57% of rural and urban women enrolled in a PMTCT programme 
respectively expressed an intention to formula feed (Doherty et al., 2005). However, shortages 
of formula milk at the health facilities, cultural factors, lack of disclosure and the stigma 
associated with formula feeding made it difficult for mothers to exclusively formula feed for 
6 months (Doherty et al., 2006). This strategy was associated with a “spillover” effect into
the HIV-negative population, who generally initiated breastfeeding after delivery but did not 
exclusively breastfeed for six months because of early introduction of solid foods and/or
infant formula (Goga et al., 2012). Furthermore early cessation of breastfeeding was prevalent 
among both HIV-positive and -negative women (Doherty et al., 2012).
The 2010 WHO HIV and infant feeding guidelines were consistent with previous iterations 
except that, where ARVs were available, HIV-positive women were encouraged to EBF for 
6 months, introduce appropriate complementary foods at 6 months and continue to breastfeed
until 12 months postpartum (World Health Organization, 2010). Following these guidelines 
the South African NDoH, in its August 2011 Tshwane Declaration of Support for 
Breastfeeding, adopted EBF for 6 months as the national infant feeding strategy for all women
and by September 2012, discontinued the provision of free infant formula as part of the 
PMTCT programme in public health facilities. 
In 2016 the WHO released an update of the 2013 consolidated ARV drug guidelines (World 
Health Organization, 2013a) that recommend lifelong ART for all HIV-positive people 
including pregnant and lactating women (World Health Organization, 2016). The risk of 
vertical transmission can be drastically reduced amongst HIV-positive breastfeeding women 
who are using ART. Furthermore it was noted that 1) replacement feeding is associated with 
a higher risk of child morbidity and mortality in resource constrained settings compared to 
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breastfeeding, 2) breastfeeding improves growth outcomes (Zunza et al., 2013), and 3) longer 
duration of breastfeeding is not only protective against infectious illnesses such as diarrhoea
and pneumonia (Mallampati1 et al., 2015) but may also offer protection from later obesity 
(Singhal and Lanigan, 2007). Consequently the WHO 2016 guideline on HIV and infant 
feeding unequivocally recommends EBF for 6 months for all women, irrespective of their 
HIV status, provided HIV-positive women are on ART and are virally suppressed, and
appropriate complementary feeding from 6 months onwards with continued breastfeeding 
until 2 years postpartum. Additionally, the update accepts any breastfeeding and mixed 
breastfeeding rather than avoiding breastfeeding (World Health Organization and United 
Nations Children’s Fund, 2016). These new guidelines were adopted in South Africa in 2017
(Pillay, 2017). Recognising the current low EBF rates in many parts of the world, the WHA 
has now set a global target to increase the 0-6 months EBF rates to at least 50% by 2025
(World Health Organization, 2014a).
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1.4 The rationale for the PhD
Given the contribution of malnutrition to childhood mortality and morbidity in the context 
of HIV, this thesis sought to answer specific questions (detailed in chapter 2) around infant 
growth in the context of HIV.
1.4.1 Analytical framework 
As this thesis considered both maternal and infant factors in the assessment of infant growth, 
a life course approach was taken into consideration (Ben-Shlomo and Kuh, 2002) which 
covered the antenatal period up through to two years postpartum. This approach is based on 
the idea that prenatal or early life exposures can influence disease risk and later health 
outcomes. Two of the research studies in this thesis recruited participants antenatally and 
followed them up postnatally. The availability of repeat measures for both the exposures and 
outcomes in these studies made it possible to assess how early life exposures affect later 
growth rates and outcomes. The life course approach could also be applied in the third study 
which, although it had a cross-sectional design, had data on prenatal exposures, and birth and 
postnatal outcomes. With regard to the multifactorial nature of malnutrition, this thesis 
primary focussed on the immediate and underlying causes, within the context of PMTCT 
policy changes (Figures 5 and 6). 
1.4.2 Paper I 
Breastmilk is not only a good source of nutrition for the growing infant but also confer
essential passive immunity to the infant. Furthermore, breastmilk has immunological 
properties that not only protect the infant from infections but also stimulates the development 
of the infant’s immune system (Akre, 1989). Although the WHO recommends EBF for the 
first 6 months of life (World Health Organization and United Nations Children’s Fund, 2016),
South Africa, a country that endorsed this infant feeding strategy for both HIV-positive and 
–negative women in 2011 (National Department of Health, 2011), continues to have relatively
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low EBF rates (National Department of Health et al., 2017) (Figure 6). Furthermore, early 
cessation of breastfeeding and introduction of complementary foods are common practices 
among both HIV-positive and -negative women. The first 1000 days of life from conception 
until 2 years postpartum, are recognised as a critical period whereby exposures can 
permanently alter the growth and developmental trajectory of a child. For example, evidence 
suggests that intrauterine growth retardation can “programme” the expression genes and 
ultimately lead to later non-communicable diseases such as cardiovascular disease and type 2 
diabetes (Barker, 1991b, Barker, 1991a, Barker, 1993, Barker, 1999). Based on this
background, this paper sought to understand how feeding practices affect growth velocity 
amongst HIV-unexposed children in the critical early months of life and how both these 
factors are related to later overweight and obesity.
1.4.3 Paper II
It is now widely accepted that malnutrition, through alterations in the immune system 
function, increases susceptibility to infectious disease and that infectious disease in-turn 
worsens malnutrition (Scrimshaw and SanGiovanni, 1997, Scrimshaw et al., 1968). Empirical 
data from fifteen studies that evaluated the association between infant HIV infection and 
growth in LMICs supports this assertion and demonstrates poor postnatal growth in HIV-
positive children (Isanaka et al., 2009). PMTCT interventions increase the chance of HIV-
exposed children to remain HIV-uninfected (Filteau, 2009, Mofenson, 2015). As the effect of 
HIV exposure on the infant is unclear this paper set out to ascertain whether HIV exposure 
has any effect on the postnatal growth rates of a cohort of children that were followed-up 
before the availability of ART. Furthermore, of the few studies that have evaluated the effect 
of HIV infection and exposure on child growth, almost all of them assessed attained growth 
between HIV-exposed and -unexposed children (Isanaka et al., 2009). This paper went a step 
further and studied both attained growth and growth velocity so as to better understand rates




Notwithstanding the benefit of ART for preventing MTCT, some studies have reported 
adverse birth outcomes with in-utero ART exposure (Jao and Abrams, 2014). These
observations could potentially have significant public health implications given that many 
countries around the globe, including South Africa, have now adopted the WHO PMTCT 
Option B+ strategy of initiating all HIV-positive pregnant women on life-long ART for 
maintenance of their health and prevention of vertical transmission (National Department of 
Health, 2014, World Health Organization, 2013a) (Figure 6). The few studies that have 
assessed these associations in South Africa were hospital based and majority of them had 
small sample sizes (Aniji et al., 2013, Jao and Abrams, 2014, Malaba et al., 2016, Malaba et 
al., 2017b, Mehta, 2017, Moodley et al., 2016). This paper therefore sought to evaluate
whether in-utero HIV and ART exposure had any adverse effects on infant birth and growth 
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Chapter 2: Thesis objectives
2.1 General objective
The general objective of this thesis is to describe child growth and its determinants in South 
Africa, a country with high malnutrition and HIV prevalences, under different PMTCT 
policies between 2002 and 2013, using the latest WHO growth standards.
2.2. Specific objectives 
Amongst HIV-unexposed children, to assess (1) the effect of early infant feeding 
practices on growth velocity in the first 6 months, and (2) the effect of both on BMI-
for-age Z-score at 2 years of age using the WHO standards: Paper I
To compare the growth velocity of HIV-exposed and -unexposed children in South 
Africa using the WHO growth velocity standards: Paper II
To study the effect of in-utero HIV and ART exposure on PTD, LBW and SGA at 
birth, and UFA at six weeks postpartum in children attending primary health care 
facilities in South Africa during established implementation of WHO PMTCT Option 
A policy using the WHO and Intergrowth-21st standards: Paper III
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Chapter 3: Study participants and methods
This chapter describes the study settings and participants and summarises the methods that 
were used to collect, manage and analyse the thesis data.
3.1 Study settings
The studies were conducted in South Africa (Figure 7 ), a country with the lowest fertility 
rate in sub-Saharan Africa (Moultrie and Timaeus, 2003), estimated at 2.84 in 2001 (Moutrie 
and Dorringtol, 2004) and declining to 2.57 by 2014 (Statistics South Africa, 2014). 
Data for the first and second objectives (papers I and II) were collected from three of the 18 
pilot districts selected for the 2001 South African PMTCT programme evaluation. These sites 
were selected to reflect PMTCT programme effectiveness in settings with varying HIV 
prevalences and socio-economic conditions. Paarl is a peri-urban area located 60km from 
Cape Town in the Cape Winelands District of the Western Cape Province. This site was 
selected because it had relatively better socio-economic conditions than the other areas, an 
antenatal HIV prevalence of 9.0% at the time of the study and a well-performing PMTCT 
programme. Most women residing in the area delivered at the Paarl Regional Hospital
(Jackson et al., 2007). Rietvlei is a rural area about 90km from Port Shepstone and is located 
in Umzimkhulu local municipality in the Harry Gwala District (previously Sisonke District)
of the Kwa-Zulu Natal Province. At the time of the study Umzimkhulu formed part of Alfred 
Nzo District in the Eastern Cape Province. In accordance with census 2001 data, this area had 
some of the most deprived wards in the Eastern Cape at the time of the study (Noble 2010). 
Rietvlei was selected to evaluate PMTCT programme effectiveness in an under-resourced 
setting with a high antenatal HIV prevalence (28.0% in 2004)(Barron et al., 2005). Umlazi is
a peri-urban township situated approximately 23km from Durban in the eThekwini District 
of Kwa-Zulu Natal Province. The antenatal HIV prevalence was 47.0% in 2004. This area 
was selected to assess the PMTCT programme effectiveness in a moderately resourced area 
with a high antenatal HIV prevalence. Clinics in the area had access to obstetric services at 
the Prince Mshiyeni Regional Hospital at the time of the study.  
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Data for the third objective (paper III) were collected in a nationally representative sample of 
580 primary health clinics and community health facilities offering immunization services in
South Africa. These facilities were part of the South African PMTCT Evaluation 
(SAPMTCTE) and were selected within each province based on their annual 6 week 
immunisation coverage and the 2008 national antenatal maternal HIV prevalence.
a) South African map with boundaries for provinces and districts delineated
b) Paarl c) Rietvlei d) Umlazi
Figure 7: Maps showing the study areas
Vundli Ramokolo
44
3.2 Data collection 
3.2.1 Study designs 
The data for this thesis comes from three studies spanning over an eleven year period between 
2002 and 2013 (Figure 6 and Table 2).  
For the first objective of this thesis (paper I) data were drawn from the PROMISE-EBF study, 
a cluster randomised trial that recruited women in pregnancy and followed them up at 3, 6, 
12 and 24 weeks and 2 years postpartum. Data collection took place between 2006 and 
January 2008. This study aimed to assess the effect of home-based EBF counselling on EBF 
rates at 12 weeks. 
For the second objective of this thesis (paper II) data were drawn from the Good Start Study, 
a prospective cohort study that enrolled pregnant women antenatally (between 34 and 36 
weeks gestation) or postnatally while still hospitalized. Eight hundred and eighty three 
consented mother-infant pairs were recruited between October 2002 and November 2004 and 
followed-up at 3, 24 and 36 weeks postpartum. This study aimed to assess the HIV vertical 
transmission rate and HIV-free survival by 36 weeks in three purposively selected sites in 
South Africa.
For the third objective of this thesis (paper III) data were drawn from the nationally 
representative SAPMCTE cross-sectional survey. Based on their annual 6 week immunisation 
coverage and the 2008 national antenatal maternal HIV prevalence, 580 primary health clinics 
and community health centres offering immunisation services were sampled within each 
province using the probability proportional to size approach. Data collection took place 
between October 2012 and May 2013. This study aimed to assess early PMTCT impact by 
measuring MTCT amongst children receiving their six weeks immunisation in selected 
facilities, regardless of their known HIV exposure or PMTCT status.
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3.2.2 Measurements
Standard anthropometric measurement techniques were used to measure weight, using 
calibrated weight scales, and recumbent length or standing height, using length boards or 
roller meters and stadiometers respectively, in papers I and II. Routinely collected 
anthropometric data, obtained using standard clinic protocols and instruments, were analysed 
for paper III. Routinely collected birthweights and gestational ages, extracted from the 
participant held road to heath booklets, were used in all three papers. In each study structured
questionnaires were used to gather data pertaining to important risk factors for child nutrition, 
such as the mother’s health information including her HIV status and ARV drug use, child 
morbidity data and infant feeding practices. Infant dietary intake was ascertained using the
24-hour and 7-day dietary recall questions in the questionnaires. Infant blood samples were 
also collected in the studies to ascertain the infant HIV exposure and infection status (Table
2).
3.3 Data management and analysis
3.3.1 Exposure variables
Only self-reported HIV-negative women and their children were considered in Paper I. The 
main exposures in this paper were infant feeding practices and growth velocity in the first few 
months of life. Table 1 shows the infant feeding definitions that were used in this thesis. The
child’s HIV infection and exposure status, and the additional antiretroviral drug exposure 
status for children born to HIV-positive mothers, was the main exposure in Papers II and III. 
In these papers the child’s HIV infection status was ascertained by the polymerase chain 
reaction (PCR) test using dried blood spot specimens obtained from the children by trained 
data collectors. No HIV testing was performed on the mothers in all the primary studies 
therefore the HIV exposure status of the children was either determined based on the maternal 
self-reported HIV status (all three papers) and/or the child HIV antibody test results (paper 
III). Amongst HIV-infected mothers in Paper III, self-reported ARV use was categorised into 
three groups: 1) ART-use primarily for mother’s health (ART-group), as per Option-A
guidelines, 2) antenatal ZDV as MTCT prophylaxis (ZDV-group) and 3) no ARV use 
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antenatally (None-group). Women on ART were further dichotomised into those who 
initiated ART pre-conception and those who started ART post-conception. These 
aforementioned groups formed the ARV exposure categories for the HIV-exposed children. 
Table 1: Infant feeding definitions
Variable Definition 
Exclusive breastfeeding (EBF) Infant received breast milk and no other nutritious foods or liquids. Oral rehydration 
solution (ORS), syrups (vitamins, minerals, medicines) are allowed
Predominant breastfeeding (PBF) Infant received breast milk and other liquids e.g. water, fruit juice, ORS, syrups 
(vitamins, minerals, medicines)
Ever breastfed Infant was breastfed at any point in time
Mixed breastfed (MBF) Infant received breast milk with nutritive liquids or solids
Exclusive formula fed (EFF) Infant received commercial infant formula milk only without any breast milk
Mixed formula fed (MFF) Infant received commercial infant formula milk with other nutritive liquids and 
solids, without breast milk
Sources: (Goga et al., 2012, World Health Organization, 2008a)
3.3.2 Outcome variables
In this thesis WAZ, WLZ, LAZ, BMI-for-age Z-scores were estimated to assess postnatal 
attained growth. These indices were interpreted as follows: children with WAZ, WLZ and 
LAZ below the minus 2 standard deviation cut-off were classified as moderately underweight, 
wasted and stunted respectively. Children with BMI-for-age Z-scores above the +2 and +3 
cut-off were classified as overweight and obese respectively (World Health Organization, 
1995a). Postnatal growth s were described using weight velocity (WVZ) and length velocity 
Z-scores (LVZ) (World Health Organization, 2009b). For perinatal outcomes universally 
recognised cut-off points were used to define LBW as birthweight below 2.5kg, PTD as birth 
before 37 completed weeks of gestation and SGA as birth weight for gestational age Z-score 
below -1.28, which is equivalent to the 10th percentile (World Health Organization, 1977)
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3.3.3 Anthropometric data cleaning
The data cleaning framework depicted in Figure 8 was used to manage the data in this thesis
(Van den Broeck et al., 2005). Anthropometric measurements were screened and flagged for 
verification if they met set criteria. The following criteria were used in Paper I: 1) WAZ<-6 
or >5, WLZ<-5 or >5, LAZ<-6 or >6, WLZ>3 and LAZ<-3; 2) extreme changes in LAZ and 
WLZ (greater than 2.5 or 3) between consecutive visits; 3) BMI-for-age Z- 6. Paper II
used these criteria: 1) decrease in length of > 2 cm between consecutive visits; 2) WAZ<-6 
or >6, WLZ<-6 or >6, LAZ<-6 or >3, WLZ>3 and LAZ<-3; 3) changes in LAZ >2.5 between 
consecutive visits and 4) Z-score changes >4 or <-4 between 24 and 36 week visits. Paper III 
used the following criteria: 1) birthweight-for-gestational age Z-score <-6 or >6; WAZ<-6 or 
>5. All the flagged observations were assessed and if no reasonable justification could be
determined, set to missing.
Figure 8: Data cleaning framework. Reproduced from an open access document. Source (Van den 




As aptly stated by Venanzio (1990) “it is not possible to describe the epidemiology of 
malnutrition with a unidirectional model of causation because its ecology is formed by a 
complex system in which every variable is affected by a multitude of other variables, giving 
rise to simultaneous interacting causal models. Poverty, political upheaval, ignorance,
taboos and feeding practices…,sanitation, water supply, family size, mother's time for child 
rearing...low wages, unemployment, epidemics and many other factors interact in a 
multidirectional way, forming a web of causation whose final outcome is malnutrition.” In 
this thesis some of the before-mentioned factors (depicted in Figure 9) were selected a
priori based on their epidemiological or clinical importance and included in the 
multivariable regression models. As causal relationships were not explored in this thesis, 
this conceptual framework is descriptive in nature and does not make definitive assumptions 
about causal pathways, the temporality of certain relationships and possible statistical
interactions
3.3.5 Data analysis
Different analytical approaches, ranging from cross-sectional to longitudinal data analysis 
methods, were used to assess growth in each paper and are summarised in Table 2. Data 
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3.4 Ethics
Details pertaining to the ethics approval documents, questionnaires and consent forms for the 
three primary studies are in the appendix.  
3.4.1 PROMISE-EBF Study (Paper I) 
Ethical approval for this study was obtained from the University of the Western Cape and the 
South African Medical Research Council. Informed consent was obtained from participants. 
3.4.2 Good Start Study (Paper II) 
Ethical approval was obtained from the University of the Western Cape and the University of 
Kwa-Zulu Natal ethical review boards. All sites used the same standard informed consent and 
information forms which were developed in English and translated into study languages 
namely; Xhosa, Zulu and Afrikaans. One consent form was signed for the interviews and 
another form was signed for HIV related testing of mother and infant. Signed informed 
consent was obtained from the participants at the time of enrolment into the study. Verbal 
consent was obtained at each visit or data collection point thereafter, including prior to every 
blood draw or other specimen collection.
3.4.3 SAPMTCTE Survey (Paper III) 
Ethical approval was obtained from the South African Medical Research Council Ethics 
Committee and United States Centers for Disease Control and Prevention (CDC) Director of 
Science. Informed consent was also obtained from all mothers/caregivers for participation in 
the study.  
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Chapter 4: Summary of Results 
This chapter presents a summary of the main findings from the three PhD papers.
4.1 Infant feeding, early weight velocity and later BMI in HIV-unexposed 
children (Paper I)
Six hundred and forty-one HIV-unexposed children that were followed-up from birth until a 
median age of 22 months (IQR: 17-26 months), hereafter referred to as the 2 years visit time,
were analysed. Although most of the children were initiated on breastmilk early, the 
proportion of breastfed children decreased in the first 12 weeks of life while the frequency of 
formula feeding increased. The early introduction of solids such as cereals was also evident
in the study. At 2 years, 30% of the children were overweight while 8.7% were obese. In this 
paper we showed that children who were not breastfed at 12 weeks had higher period-2 
(between 12 and 24 weeks ) mean WVZ, higher BMI-for-age Z-scores at 2 years and were 
more likely to be overweight or obese. We also observed a positive association between the 
period-2 mean WVZ and BMI-for-age Z-score at 2 years.
4.2 Growth velocity of HIV-exposed and -unexposed children (Paper II)
Of the 883 children that were recruited, 783 children (including 65 HIV-positive children,
502 HEU children and 216 HUU children) were analysed. The mean WAZ of HIV-infected
children was lower at 3, 24 and 36 weeks than that in the other two groups. Similar results 
were observed for mean WVZ in period-1 (3-24 weeks postpartum). Although no differences 
in mean LAZ and WLZ were observed at 3 weeks, HIV-positive children had lower mean 
LAZ and WLZ at 24 and 36 weeks. These children also had the lowest mean LVZ in period-
1. No significant differences in the mean WAZ, LAZ, WLZ, WVZ and LVZ were observed 
between HEU and HUU children. Mean WVZ varied by feeding mode, with MFF children
demonstrating a higher mean WVZ than children that were EBF. 
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4.3 Birth and growth outcomes of in-utero ART exposed HEU children
(Paper III)
Of the 9119 children that were in the final survey sample, 8778 (consisting of 2599 HEU and 
6179 HUU children) were included in the analysis. The prevalence (95% confidence 
intervals) of PTD, LBW, SGA and underweight-for-age (UFA) at six weeks postpartum were
12.5% (11.4%; 13.7%), 10.7% (10.0%; 11.5%), 14.9% (13.8%; 16.1%) and 9.2% (8.6%; 
10.0%) respectively in the total sample. As illustrated in Figure 10 below, the prevalence of 
PTD was similar between HUU (12.3% (11.1%; 13.7%)) and HEU (12.9% (11.12%; 14.7%)) 
children (P=0.59) in the unadjusted analysis, whereas the latter group had a higher prevalence 
of LBW (13.0% vs 9.8%, P<0.01), SGA (16.9% vs 14.0%, P=0.03) and UFA (8.4% vs 11.0%, 
P<0.01). In the multivariable logistic models HEU children demonstrated a higher odds of 
PTD, LBW, SGA and UFA than HUU children. Within the HEU sub-group, children in the 
None-group (1.9 (1.1; 3.1)) or those whose mothers initiated ART pre-conception (1.7 (1.1; 
2.5)) had almost twice the odds of PTD than children whose mothers initiated ART post-
conception. In this study a reduced odds of UFA was observed if the infant was breastfed 
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Chapter 5: Discussion
5.1 Discussion of main findings and implications 
The overall objective of this thesis was to describe child growth and its determinants in South 
Africa, a country with high malnutrition and HIV prevalences, under different PMTCT 
policies between 2002 and 2013, using the latest WHO growth standards. To achieve this 
objective data from two prospective follow-up studies and one nationally representative cross-
sectional survey, spanning over an eleven year period between 2002 and 2013, were analysed
and the WHO attained growth and growth velocity standards were applied to the data. For the 
cross-sectional study Intergrowth-21st standards for the foetal growth of both term and 
preterm born children were also applied. This thesis therefore makes several empirical and 
methodological contributions to the field of nutritional epidemiology. 
5.1.1 Contribution of the thesis and future areas of research 
The HIV-infected child
The results presented in chapter 4 contributed to the existing literature by demonstrating that 
HIV-infected children are not only more underweight, wasted and stunted compared to HEU 
and HUU children, but also have lower growth rates in the first few of months of life. The 
majority of the previously published studies only assessed attained growth between HIV-
exposed and -unexposed children (Isanaka et al., 2009). Paper II went a step further and 
assessed both attained growth and growth velocity so as to better understand rates of growth 
in HIV-exposed and -unexposed children. The study demonstrated that maternal viral load, 
low birth weight and Nevirapine use were independent predictors of growth velocity in HIV-
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exposed children and that HIV-positive children had increased infectious morbidity compared 
to HUU children.
The HIV exposed uninfected child
Over the past decade significant progress has been made in reducing vertical HIV 
transmission through the scale-up of PMTCT interventions such as maternal ART use during 
pregnancy. As a result HEU children now constitute the majority of the children affected by 
the HIV pandemic (Filteau, 2009, Mofenson, 2015). Very few follow-up studies have 
examined the growth of HEU children compared to a healthy group of HUU children (the 
controls) in LMICs. Of the few that have, some did not adequately characterise the maternal 
and child HIV status, thereby making it difficult to compare growth by HIV exposure and 
infection status (Isanaka et al., 2009). Paper II, using data from a well characterised group of 
HIV-exposed and -unexposed children followed-up before the generalised use of ART for 
PMTCT, demonstrated that HEU children had similar attained growth and growth velocities 
compared to HUU children in the absence of maternal ART. These findings confirm those 
reported in other longitudinal studies that were conducted before the wide scale use of ART
(Isanaka et al., 2009). However some studies have reported differences in the growth of HIV-
exposed compared to HIV-unexposed children (Masaka M., 2007, Rosala-Hallas et al., 2017).
The generalised use of ART by pregnant and lactating women in recent years makes it more 
difficult to measure the true effect of HIV exposure on child growth. Unlike in paper II, and
in line with more recent evidence (Evans et al., 2016, Jao and Abrams, 2014, Powis et al., 
2016, Sudfeld et al., 2016) data from Paper III, drawn from research conducted when South 
Africa was scaling up its ART programme, demonstrated that HEU children had poorer birth 
and early postnatal growth outcomes compared to HUU children. In Paper III, as not all HIV-
infected women were on ART, for various reasons including ART eligibility criteria, we could 
compare outcomes by HIV and ART exposure status. In line with findings from Turner et al. 
(2013), the results in Paper III demonstrated that HEU children born to women with 
unmanaged HIV infection had an increased odds of being born preterm than children born to 
women on ART. These results provide reassuring evidence for the current WHO and South 
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African PMTCT guidelines that recommend that HIV-infected pregnant women should be 
placed on ART for maintenance of maternal health status and prevention of vertical 
transmission (National Department of Health, 2014, World Health Organization, 2013a).
Similar to recent data from other observational studies, the results in Paper III also
demonstrated that children whose mothers initiated ART before conception had an increased 
odds of preterm delivery than children whose mothers started ART after conception (Uthman 
et al., 2017) , but no increased odds for other outcomes. Although the observed associations 
could be due to selection bias (Stringer et al., 2017), this data suggests that the 1) timing of 
ART initiation maybe an important predictor of child health outcomes, and 2) need for 
pregnancy registers or similar pharmacovigilance surveillance systems to monitor adverse 
outcomes in order to inform future policy. More in-depth research is also required to 
understand the mechanisms through which in-utero HIV and ART exposure may affect child 
health outcomes. As a way of unpacking possible mechanisms, Evans et al. (2016)
summarised current knowledge in a conceptual framework depicting the complex network of 
factors that may lead to the growth failure, morbidity and mortality of HEU children through 
pathways that operate through immunodeficiency and chronic inflammation. Taken together 
these results suggest that both the exposure to a disease and the infection are important 
predictors of child malnutrition. This medical dilemma where the need to initiate HIV-
positive pregnant women on ART early to improve maternal health and prevent MTCT is 
juxtaposed against the need to prevent potential drug-related adverse infant outcomes remains 
to be resolved. Additional in-depth research is needed.
Infant feeding 
In line with findings from other studies (Sibiza et al., 2015), results presented in Paper I
indicate that poor breastfeeding practices still persist in South Africa despite the known 
benefits of breastfeeding. Studies have found that breastfeeding can be protective against 
infectious morbidity such as diarrhoea and respiratory infections, child hospital admissions 
and mortality (Victora et al., 2016). Findings from Paper I demonstrated that breastfeeding 
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conferred a protective effect not only against underweight, but was also protective against 
rapid weight gain (weight velocity) in the first few months of life and, similar to findings in 
other studies (Singhal and Lanigan, 2007, Victora et al., 2016), later overweight or obesity. 
This is an important finding as South Africa has persistent chronic undernutrition in children
and an increasing burden of overnutrition in the child and adult population (National 
Department of Health et al., 2017, Said-Mohamed et al., 2015). In addition the prevalence of 
obesity in South Africa ranks first in Sub-Saharan Africa (Ng et al., 2014). The latest South 
African Demographic and Health Survey results indicate that 68% of women and 31% of men 
are overweight or obese (National Department of Health et al., 2017). Breastfeeding, which 
has been identified as one of the key nutrition-specific interventions for addressing the 
immediate determinants of foetal and child nutrition, could help curb the rise of childhood 
overweight or obesity and the subsequent epidemic in the adult population (Ruel et al., 2013).
Some studies have found that breastfeeding is not only beneficial for the infant but may also 
protect the nursing mother against type 2 diabetes; its effect on maternal post-delivery weight 
change is however inconclusive (Victora et al., 2016). Although the prevalence of EBF in 
children aged 0-6 months has increased from 8% to 32%, more efforts are required to 
promote, protect and support breastfeeding in South Africa as it is still below the WHA target 
of increasing the 0-6 months EBF rates to at least 50% by 2025 (World Health Organization, 
2014a). 
5.2 Methodological considerations
5.2.1 Study design 
This thesis aimed to describe child growth and its determinants in South Africa, a country 
with high malnutrition and HIV prevalences, under different PMTCT policies between 2002 
and 2013, using the latest WHO growth standards. Therefore the study designs used in this 
thesis were not only descriptive, giving the occurrence of a disease in a population, but also 
analytical enabling the researcher to examine how particular exposures relate to the 
development of certain disease outcomes. The following study designs were therefore used:
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Cluster randomised trial: Paper I
Although the primary research study for Paper I had a cluster randomised trial design, which 
is experimental in nature, for the purposes of this thesis the data were treated as data from a 
cohort study given that the trial intervention (infant feeding counselling (Tylleskar et al., 
2011)) was not the exposure of interest in this thesis. The study was therefore treated as a 
prospective cohort study of HIV-negative women and their children followed-up from 3 
weeks until 2 years postpartum. Unlike randomised controlled trials, which try to achieve 
counterfactuality between the comparison groups by 1) minimising the variation in the 
outcome that is due to extraneous factors (referred to as confounders) by randomly allocating 
the treatment or exposure, 2) measuring any residual variation that exists so it can be taken 
into account in the analyses and 3) blinding the participants and investigators, cohort studies 
are subject to selection bias which can affect the exchangeability of the comparison groups 
(Rothman et al., 2008a). To minimise this bias potential confounders were adjusted for in the 
regression models.
Prospective analytical cohort study: Paper II
The research study for Paper II had a prospective analytical cohort study design which is 
observational in nature, and entailed following-up mother-infant pairs from pregnancy until 
36 week postpartum. This study design enabled us to 1) establish that the exposure preceded 
the outcome and therefore to examine the association between infant HIV exposure and 
infection and postnatal growth rates and 2) explore associations between the outcome and 
more than one exposure. However this cohort study design limited the extent to which we 
could infer that observed associations were causal in nature because of potential selection bias 
and confounding. As with most cohort studies, this study had participants that were lost to 
follow (LTFU) (Myer and Karim, 2007). A comparison of characteristics between 
participants that were observed until the end of the study versus those that were LTFU failed 
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to identify significant differences between the groups. Therefore we do not believe that LTFU 
biased the study results. Furthermore to minimise the possible effect of selection bias potential 
confounders were adjusted for in the regression models.
Analytical cross-sectional survey: Paper III
Paper III utilised a cross-sectional survey design. Unlike in the cohort studies, which had a 
follow-up period, in this cross-sectional study the exposures and outcomes were assessed at 
one point in time. Although this feature makes it difficult for most investigators conducting 
cross-sectional studies to ascertain the temporal relationships between the exposures and 
outcomes, the theoretical basis of the main relationships we considered in this study makes 
us believe that the likelihood of reverse causality was low. However information bias may 
have affected our results as some of our key variables were not objectively measured. For 
example, maternal ART use during pregnancy was obtained by recall and the gestational age 
data that were analysed were estimated by public healthcare facility staff, likely using the last 
menstrual period (LMP) method which tends to overestimate the prevalence of preterm 
delivery compared to ultra-sound based preterm estimates (Malaba et al., 2017a). The major 
strength of this study design is that it is more affordable, compared to study designs such as 
cohort studies, so it enabled us to examine our research question in a large sample. 
5.2.2 Sample sizes
Given that it is impractical to study research questions by collecting data from an entire 
population, a representative sample of the population of interest is often studied and the study 
findings generalised at the population level. The research questions addressed in this thesis 
were not the principal questions in the studies undertaken, therefore the sample sizes and 
statistical power estimations for the secondary outcomes were not determined a priori.
Samples sizes that were used in this thesis were therefore the result of the sample size 
estimations done for the primary research questions.
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At the time of the analysis, some participant data were incomplete because 1) they were 
determined to be implausible during the data cleaning process and therefore coded as missing,
or 2) participant non-response during the interviews, or 3) participants were lost to follow-up
(LTFU) during the studies. Missing data can introduce bias, type I and II error in an analysis
(Little et al., 2016). In Paper I some participants were not followed up until the 2 year visit 
time. However we do not believe that this LTFU biased the results because the baseline 
characteristics of the LTFU participants were very similar to those of participants that were 
observed at 2 years. In addition all three PhD papers used maximum likelihood estimation 
which models parameters and standard errors using all available data and assumes that any 
missing data are missing at random (Little et al., 2016). In Paper III survey weights were 
added to all analyses in order to maintain the sampling structure of the survey structure. 
Additional weighting for missing gestational age data (which were missing for 29% of the 
participants) was applied to the PTD and SGA analyses.
5.2.3 Internal validity
Confounding, selection and information bias can compromise the internal validity of a study 
(Greenland et al., 2008). In this thesis potential confounders were identified a priori based on 
literature and were primarily controlled for using multivariable regression modelling. Only 
potential confounders that were measured were controlled for therefore residual confounding 
may have remained after the adjustments in the multivariable regression models. Selection 
bias is also possible in this thesis as, for ethical and logistical reasons, each study excluded 
participants in accordance with certain exclusion criteria. For example, sick children needing 
emergency care, children that died before the 6 week clinic visit and children attending small 
remote health facilities were excluded from the study that contributed to Paper III. The 
exclusion of some the most vulnerable children in this study may explain why our rate of 
LBW was lower than the national estimate which is based on all lives births in South Africa.
To minimise information bias all data collectors in the research studies undertaken for this 
thesis received standardized training on anthropometric techniques. For papers I and II the 
anthropometry data collection was also validated periodically in order to improve validity and 
reduce inter-observer and intra-observer bias. The use of routinely collected anthropometric 
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data in paper III precluded the ability of the researchers to minimise these biases in paper III. 
Recall bias is also a type of information bias. The results presented in this thesis are subject 
to recall bias as certain data were ascertained through recall. For example in all 3 research 
studies participants were asked questions about what they fed their children in the previous 
24 hours and seven days using dietary recall questionnaires. The validity of the dietary 
information acquired using this method may be compromised because participants may 1) 
alter their dietary patterns if the study is focused on their diets, a phenomenon called the 
Hawthorne effect, 2) participants may not recall all the foods they have consumed (Walsh and 
Joubert, 2007). In addition short-term dietary recall data, such as feeding practices reported
for the previous 24 hours or seven days, does not accurately capture long-term feeding 
patterns (Bland et al., 2003). Nevertheless the use of this dietary assessment method in this 
thesis has the following advantages: 1) unlike the dietary records method which relies on 
participants to accurately record their diets, the dietary recall questionnaires were 
administered by well-trained data collectors so illiterate participants could also be included in 
the studies, 2) group-level dietary data collected using this method are fairly valid (Thompson 
and Byers, 1994). The misclassification of participants may have also occurred in this thesis. 
In Papers I and II no maternal HIV and child HIV antibody tests were done during the course 
of the studies therefore some of the HIV-negative women may have seroconverted leading to 
the misclassification of children as HIV-unexposed. In Paper III HIV-positive mothers were 
further categorized into ARV groups based on self-reported ARV drug use which is subject 
to recall bias. Therefore some participants may have been misclassified in the ARV groups. 
All the studies that contributed to this thesis had some degree of missing data including 
biologically implausible anthropometric measurements that were set to missing during data 
cleaning. In Paper I mixed effect regression was therefore used to analyze the incomplete 
longitudinal data as it uses all available longitudinal data without discarding data for children 
with missing data. These models also adjust for the correlation that exists between repeated 
measurements taken from the same child or group of children (Fitzmaurice et al., 2011).
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5.2.4 External validity
External validity is concerned with generalisability of the study findings to the larger 
population or populations in other settings (Rothman et al., 2008b) and is closely linked to 
the inclusion and exclusion criteria that were used to select participants for the study. 
Therefore the generalisability of the study findings in this thesis is limited to populations that 
have similar characteristics (such as social, demographic, economic and epidemiological 
patterns of HIV and malnutrition in the setting) to those of the participants that were studied.
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Chapter 6: Conclusions and recommendations
This thesis highlights the importance of not only addressing the double burden of malnutrition 
in South Africa, but also the burden of colliding disease epidemic of communicable and non-
communicable diseases. The strong association observed between infant HIV infection and 
poor growth highlights the importance of addressing the unfinished agenda of combating the 
HIV epidemic by striving towards the global UNAIDS goals of ensuring that 90% of all 
people living with HIV know their status, 90% of all those who are diagnosed with HIV are 
sustained on ART and 90% of those on ART are virally suppressed in order to prevent vertical 
transmission and improve both maternal and infant health. There is also an urgent need to 
tackle persistent undernutrition in both HIV-exposed and -unexposed South African children 
while curbing the concomitant rise of overnutrition, possibly thorough facility and community 
based support programmes that encourage longer durations of breastfeeding and avoidance 
of early introduction of complementary foods. As more HIV-positive women are placed on
ART vertical transmission declines and more children are born HEU. While early initiation 
of HIV-positive women on is important for preventing MTCT and maintenance of maternal 
health, data does signal that pre-conception initiation of ART may have an adverse effect on 
PTD. As access to ART increases routine surveillance system should be set up to monitor 
adverse outcomes. The emergence of a large population of HEU for whom there are limited 
data also warrants the urgent need for the close follow-up, through surveillance systems and 
in-depth cohort studies, of this sub-population of children in order to assess not only short 
term outcomes but also longer-term outcomes of HIV and ART exposure as the intrauterine
programming may lead to adult disease.
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Effects of early feeding on growth velocity and
overweight/obesity in a cohort of HIV unexposed
South African infants and children
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Abstract
Background: South Africa has the highest prevalence of overweight/obesity in Sub-Saharan Africa. Assessing the
effect of modifiable factors such as early infant feeding on growth velocity and overweight/obesity is therefore important.
This paper aimed to assess the effect of infant feeding in the transitional period (12 weeks) on 12–24 week growth
velocity amongst HIV unexposed children using WHO growth velocity standards and on the age and sex adjusted body
mass index (BMI) Z-score distribution at 2 years.
Methods: Data were from 3 sites in South Africa participating in the PROMISE-EBF trial. We calculated growth velocity
Z-scores using the WHO growth standards and assessed feeding practices using 24-hour and 7-day recall data. We used
quantile regression to study the associations between 12 week infant feeding and 12–24 week weight velocity (WVZ) with
BMI-for-age Z-score at 2 years. We included the internal sample quantiles (70th and 90th centiles) that approximated the
reference cut-offs of +2 (corresponding to overweight) and +3 (corresponding to obesity) of the 2 year BMI-for-age Z-scores.
Results: At the 2-year visit, 641 children were analysed (median age 22 months, IQR: 17–26 months). Thirty
percent were overweight while 8.7% were obese. Children not breastfed at 12 weeks had higher 12–24 week mean WVZ
and were more overweight and obese at 2 years. In the quantile regression, children not breastfed at 12 weeks had a 0.37
(95% CI 0.07, 0.66) increment in BMI-for-age Z-score at the 50th sample quantile compared to breast-fed children. This differ-
ence in BMI-for-age Z-score increased to 0.46 (95% CI 0.18, 0.74) at the 70th quantile and 0.68 (95% CI 0.41, 0.94) at the 90th
quantile . The 12–24 week WVZ had a uniform independent
effect across the same quantiles.
Conclusions: This study demonstrates that the first 6 months of life is a critical period in the development of childhood
overweight and obesity. Interventions targeted at modifiable factors such as early infant feeding practices may reduce the
risks of rapid weight gain and subsequent childhood overweight/obesity.
Introduction
The first 1000 days from conception to 2 years are a crit-
ical period in the growth and development of infants [1].
Insults or stimuli in the intrauterine environment, including
maternal body composition and diet, can “programme” the
expression of genes and lead to permanent physiological or
morphological changes in the fetus [2-4]. Programming
can extend into the postnatal period where infant feeding
and infant growth patterns can further predispose infants
to later cardiovascular disease, overweight and obesity and
other chronic disease; a phenomenon called “developmen-
tal origins of health and disease”[2,5]. Evidence from twin
studies suggests that rapid weight gain between birth and
3 months is primarily influenced by modifiable environ-
mental influences in term babies [6-13], such as nutrition
[14], whereas from 5 months onwards genetic factors play
a larger role [7,9,15].
* Correspondence: vundli.ramokolo@mrc.ac.za
ˆDeceased
1Health Systems Research Unit, South African Medical Research Council,
Cape Town, South Africa
2Centre for International Health, Department of Global Public Health and
Primary Care, University of Bergen, Bergen, Norway
Full list of author information is available at the end of the article
© 2015 Ramokolo et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Ramokolo et al. International Breastfeeding Journal  (2015) 10:14 
DOI 10.1186/s13006-015-0041-x
The World Health Organisation (WHO) recommends
exclusive breastfeeding (EBF) until 6 months of age and
timely introduction of appropriate complementary foods
with continued breastfeeding up to 2 years or beyond
[16]. EBF protects infants from rapid weight gain in the
postnatal period, a risk factor for insulin resistance and
later overweight and obesity which are both prevalent in
South Africa [17,18]. Breastfeeding practices are still
poor in South Africa as only 8% of infants 0–5 months
are EBF [19]. We have shown that a third of infants who
initiated breastfeeding in our sample were introduced to
other foods, particularly formula, from as early as 3 days
[20]. By 12 weeks postpartum 20% and 40% of HIV
negative and positive women respectively had stopped
all breastfeeding and transitioned to other liquids and
solids Data from observational studies showed that chil-
dren introduced to complementary foods earlier than 3
or 4 months, compared with later introduction, were
more likely to be overweight or obese [21-24]. A rando-
mised controlled trial also showed that high protein in-
take in infant formula was associated with rapid weight
gain in the first 2 years of life [25]. Here we aimed to as-
sess the effect of infant feeding in the transitional period
(12 weeks) on 12–24 week growth velocity amongst HIV
unexposed children using WHO growth velocity stan-
dards [26], which can adequately describe the growth of
South African children [27], and on the age and sex ad-
justed body mass index (BMI) Z-score distribution at
2 years. We used data from the PROMISE-EBF (Clicinal-
Trials.gov.no: NCT00397150) trial; a multi-country
cluster randomized community trial primarily asses-
sing the effect of home based EBF counselling on EBF
rates at 12 weeks [28].
Methods
Study design and participants
The present paper includes data from the three South
African sites of the PROMISE-EBF behavioural-
intervention trial that sought to improve EBF rates
through peer counselling, conducted between 2006
and January 2008: Paarl (mixed peri-urban/rural area),
Rietvlei (rural area) and Umlazi (peri-urban formal
township). Trial methods have been described in detail
elsewhere [28,29]. Briefly, pregnant women in their last
trimester of pregnancy were screened for inclusion
into the study. A total of 964 HIV negative and 184
HIV positive women and their singleton children were
enrolled at the 3 week postnatal visit and followed up
at 6, 12 and 24 weeks . Six hundred and fifty four HIV
unexposed children (67.8% of original cohort) followed
up again between March and September 2008 at a me-
dian age of 22 months (IQR: 9–34 months), which we
refer to as the 2 year visit, were considered for this
analysis due to the described negative effect of HIV
infection on growth [27]. We compared baseline char-
acteristics of participants that were followed-up at
2 years with those that were not (see Additional file 1)
and observed no systematic differences, besides the
proportion of male children, between the groups. This
suggests that the sample that was followed-up is generally
representative of the children in the whole cohort. A
further 13 children were excluded because of extreme
and implausible anthropometric values leading to a final
sample of 641 children.
Data collection
Standardised questionnaires were used to collect inter-
view data during pregnancy and postnatally at 3, 6, 12
and 24 weeks, and at the primary endpoint of 2 years of
age. Maternal variables included: age, parity and educa-
tion which were captured during recruitment; delivery
mode and reported HIV status collected at the 3 week
visit. The questionnaires also addressed infant feeding
practices through 24-hour and 7-day recall of a list of 23
foods commonly consumed in the study sites. No food
diaries were used. Data on child birth weight were extracted
from perinatal records.
Field staff measured child weight and recumbent
length/height during the 3, 6, 12, and 24 weeks visits
and at 2 years. Children were weighed to the nearest
0.1 kg on Masskot (SOS Series) electronic pan scales,
which were calibrated weekly using a 2 kg weight, wearing
minimum clothing and no shoes. Depending on the study
site, recumbent length measurements were obtained to
the nearest 0.1 cm using TALC roller meters (Oxford,
UK) or Shorr Height-Length Measuring Board (Maryland,
USA) while height was measured using a validated
ustom-made stadiometer. All field workers were trained
on anthropometric techniques. In order to improve valid-
ity and reduce inter and intra-observer bias, the anthro-
pometry data collection was validated periodically. Child
age was calculated using the date of birth from the Road
to Health card and the date of the interview.
Data were double-entered into a Microsoft Access data-
base and analysed using Stata SE 12 [30] and IBM SPSS
Statistics 21 [31].
Anthropometric scoring
The primary outcome measure was BMI-for-age Z-scores
at 2 years; secondary outcomes were weight velocity
Z-scores (WVZ) and length velocity Z-scores (LVZ).
We calculated BMI-for-age Z-scores at the 12 week
and 2 year visits, standardised for sex and actual age
at the respective visit, using the WHO growth stan-
dards [32]. We considered children as “overweight”
and “obese” if their BMI-for-age Z-scores were above +2
and +3 respectively as recommended by the World Health
Organisation [33]. A macro based on the WHO-2009
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growth velocity standards was used to compute the
WVZ and LVZ. Velocities were calculated for a first
period, namely from 3 or 6 to 12 weeks post-delivery,
and for a second period, namely 12 to 24 weeks post-
delivery. In cases where the 3 or 6 week weight was
missing we used the birth weight for the calculation of
velocity in the first period. The age intervals and child
ages observed in the study did not always correspond
exactly with those of the velocity standards. Thus the
velocity Z-scores were calculated, as recommended by
WHO, by identifying the best-fitting age interval for
each child period observed and linearly extrapolating
the observed increment in the child period to the dur-
ation of the best-fitting target interval [26].
Data cleaning
Anthropometric measurement values and Z-scores were
flagged for verification if any of the following criteria
were met: a) decrease in length of more than 2 cm be-
tween two consecutive visits; b) WAZ <-6 or >5, WLZ
<-5 or >5, LAZ <-6 or >6, WLZ >3 and LAZ <-3; c) ex-
treme changes in LAZ between visits defined as LAZ at
3 weeks < 2 and LAZ at 24 weeks > 2.5, or LAZ at
24 weeks < 2 and LAZ at 36 weeks > 2.5; d) changes > 4
or <-4 Z-scores between 24 and 36 weeks and BMI-for-
age Z-score ≥6. All the flagged anthropometric observa-
tions were assessed and values treated as missing if no
plausible explanation was determined.
Feeding pattern
We used a combination of 24-hour and 7-day infant
feeding recall data at each follow-up visit to generate
time specific food consumption indicator variables (for
breast milk, water, sugar water, formula, cereals, fruits/
vegetables, traditional herbs, prescribed and non-
prescribed medicines) with 3 categories: yes, no and
missing. For example if the caregiver said that she gave
the child breast milk in the previous 24-hours or 7-days
then we coded that child as having received breast milk.
If the caregiver said “no” to both questions on breast
milk, the child was then considered as one that did not
receive breast milk. The response was coded as “miss-
ing” for breast milk if data were missing for both ques-
tions. Cross-tabulation of the 12 week breast milk and
formula indicators revealed that all children had con-
sumed at least one of the two foods. Based on exploratory
analysis we combined two of the three combinations of
these feeding indicators and this resulted in a binary ‘ever
breastfed” variable with the following categories: yes
(received breast milk with other solids and liquids
which may include formula) and no (received formula
and other liquids and solids except breast milk). The
12 week breastfeeding cessation variable was defined
as no breastfeeding at the 12 week interview (based on
24-hour and 7-day recall) and no breastfeeding re-
ported for the subsequent final 24-week interview.
Only children who initiated breastfeeding by the 3 week
visit were considered in this definition.
Statistical analysis
Unlike the ordinary least squares (OLS) regression
which only considers the conditional mean function, we
used quantile regression which is a statistical technique
that provides a more detailed analysis of the relationship
between the dependent variable and its independent var-
iables because it provides conditional regression coeffi-
cients for each quantile, [34,35]. We used univariate and
multivariate simultaneous quantile regression to test
whether 12 week infant feeding and 12–24 week growth
velocity (adjusting for other variables) had increased ef-
fects over the upper tails of the conditional distribution
of BMI-for-age Z-scores at 2 years. For this analysis we
included the internal sample quantiles (70th and 90th
centiles) that approximate the reference cut-offs of +2
and +3 Z-scores for BMI-for-age around 2 years. We
also performed OLS regression modelling. The following
variables were adjusted for in the multivariate models
because of their epidemiologic or clinical importance:
birth weight, maternal age, parity, maternal education,
study arm and site. Although the child’s age and sex
were taken into account in the BMI-for-age Z-score esti-
mations, based on previous literature [36] we included
an interaction term between the infant feeding and sex
variables in initial regression models to test whether sex
modifies the relationship between feeding and BMI-for-
age Z-score. This interaction term was excluded from
the final models as no effect measure modification was
detected. Maternal age and parity were excluded from
the final multivariate model because they were not sig-
nificantly associated with 2-year BMI in the univariate
analysis. The Breusch-Pagan / Cook-Weisberg test was
used to check for heteroskedasticity and trends across
the quantile regression percentiles were also tested. Con-
tinuous data are presented as mean ± SD or median
(IQR) while categorical variables are presented as fre-
quencies. We used the Student t-test to compare means
and the Pearson chi-square test to examine associations
in the cross-tabulations. Statistical tests were two-sided
and performed at the 5% significance level. Kernel density
functions were used to estimate the 2 year BMI-for-age
Z-score distribution stratified by the 12 week overweight
and breastfeeding while the two-sample Kolmogorov-
Smirnov test was used to test for equality of the distribu-
tion functions.
Ethical approval
The PROMISE-EBF trial was approved by the Regional
Committees for Medical and Health Research Ethics
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(REK VEST) in Norway (issue number 05/8197), University
of the Western Cape (research registration number 0607/8)
and the South African Medical Research Council (protocol




Six hundred and forty one HIV unexposed children with
valid weight and length data (median age 22 months,
IQR: 17–26 months) were analysed at the 2-year visit
(Figure 1). Table 1 summarises the characteristics of
these children and their mothers. Rietvlei had slightly
fewer male children compared to the other sites and
more children with birth weight >4 kg. About half the
children were firstborn and Paarl had the highest fre-
quency of vaginal births.
Infant feeding
The proportion of children consuming any breast milk
decreased from 89.3% (95% confidence interval (CI),
86.5, 91.7%) at 3 weeks to 79.4% (95% CI 75.8, 82.6%) at
12 weeks (Table 2). In contrast there was an increase in
the proportion of children consuming formula from
48.5% (95% CI 44.5, 52.5%) to 62.9% (95% CI 58.8,
66.9%) and cereal from 28.6% (95% CI 25.1, 32.3%) to
63.4% (95%CI 59.4, 67.4%) between the 3 and 12 weeks.
Cereals were consumed by 79.5% (95% CI 71.0, 86.4%) of
children who were not breastfed at 12 weeks and 59.6%
(95% CI 54.9, 64.1%) of those who were breast-fed
(P < 0.001). Formula was consumed by all non-breastfed
children at 12 weeks and 53.7% (95% CI 49.0, 58.4%) of
the breastfed children (P < 0.001).
Weight and length velocity
The overall mean WVZ varied between the feeding
groups in both postnatal periods while no differences
were observed for mean LVZ (Table 3). In period-1, chil-
dren who received no breast milk at 3 weeks had a
higher mean WVZ compared to children who received
any breast milk (P < 0.01). The same association was ob-
served between 12 week feeding and the period-2 mean
WVZ. Comparable results were obtained when mean
weight and length values were compared in place of vel-
ocity Z-scores (Additional file 2). Period-2 mean WVZ
also differed by breastfeeding cessation with children
who stopped all breastfeeding by 12 weeks (n = 116) hav-
ing a higher (P = 0.02) mean WVZ than children who
continued breastfeeding (n = 47), data not shown.
Breastfed and non-breastfed children
Thirty percent of all children were overweight at 2 years
while 8.7% were obese. The estimated 2 year BMI-for-age
Z-score density distribution for our sample is depicted in
Figure 2 and is shifted to the right of the referent standard
expected normal distribution. The unadjusted effect of
breastfeeding status at 12 weeks (P = 0.08) on 2 year BMI-
for-age Z-score is depicted in Figure 3. The mean and
upper tail of the BMI-for-age Z-score density distribution
for children who were not breastfed at 12 weeks are
shifted to the right of the distribution for breastfed chil-
dren. The adjusted linear regression showed similar results
with the mean BMI-for-age Z-score at 2 years for children
Figure 1 3, 6, 12 and 24 week and 2 year weight and length data of 641 infants that were seen until the final visit.
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who were not breastfed at 12 weeks 0.32 (95% CI 0.04,
0.61) higher than for breastfed children (Table 4).
Table 4 and Figure 4 present the adjusted OLS and
multivariate quantile regression models (detailed table
with the adjusted OLS and multivariate quantile regres-
sion models for all the covariates is in Additional file 3).
The adjusted quantile regression model showed an over-
all significant linear trend between breastfeeding and
BMI-for-age Z-score at 2 years (P = 0.01). Breastfeeding
had an increasingly protective effect on the 2 year BMI-
for-age Z-score conditional distribution from the 60th
quantile (Table 4 and Figure 4), and this effect was most
pronounced at the 90th quantile which corresponds with
the definition for obesity in our sample. Children who
were not breastfed at 12 weeks had a 0.37 (95%CI 0.07,
0.66) increment in BMI-for-age Z-score at the 50th
quantile compared to breast-fed children. This difference
in BMI-for-age Z-score increased to 0.46 (95% CI 0.18,
0.74) at the 70th quantile and was 0.49 (95% CI 0.16,
0.83) and 0.68 (95% CI 0.41, 0.94) at the 80th and 90th
quantiles respectively. No significant point estimates
were observed for infant feeding between the 10th and
40th quantiles. The 12 week BMI-for-age Z-score and
period-2 WVZ regression coefficients showed uniform
positive effects across the quantiles of 2 year BMI-for-
age Z-score. The birth weight regression estimate tended
to be positively associated with quantiles of the 2 year
BMI-for-age Z-score and increased towards the upper
tails of the distribution (Additional file 3). The assump-
tion of homoscedasticity was not violated in the model
(P = 0.52).
Discussion
Maternal and child malnutrition, which include both
under and over nutrition, are a growing concern in low
and middle income countries [37]. South Africa has the
highest prevalence of obesity in Sub-Saharan Africa with
42% of women, aged ≥20 years, obese and a quarter of
girls younger than 20 years overweight/obese [38]. This
high prevalence of obesity among women of child bear-
ing age raises concerns as pre-pregnancy overweight/
obesity and excessive gestational weight gain are risk
factors for gestational diabetes, pregnancy induced
hypertension [39] and adverse birth outcomes such as
macrosomia. Furthermore, evidence shows that infants
of obese mothers have twice the odds of being obese at
2 years compared to infants of non-obese mothers [40].
Childhood obesity is in turn a risk factor for adult obes-
ity, diabetes and non-communicable disease [41]. To
prevent this cycle of obesity, both the determinants and
Table 1 Participant characteristics by site
Variables Paarl (N = 258) Rietvlei (N = 189) Umlazi (N = 194)
n % n % n %
Infant gender, (% male) 142 55.0 92 48.7 113 58.3
Birth weight, (%)
Low birth weight (<2.5Kg) 21 8.1 6 3.2 11 5.7
Normal birth weight (2.5- < 4Kg) 219 84.9 134 70.9 172 88.7
Macrosomia (≥4Kg) 11 4.3 16 8.5 7 3.6
Missing 7 2.7 33 17.5 4 2.1
Maternal age (y), %
15–25 160 62.0 122 64.6 134 69.1
26–44 98 37.9 67 35.5 60 30.9
Parity, %
Primipara 126 48.8 78 41.3 114 41.2
Multipara 132 51.2 111 58.7 80 41.2
Maternal education (grade), %
0–7 28 10.9 37 19.6 9 4.5
8–10 117 45.4 108 57.1 53 27.3
11–12 109 42.3 44 23.3 114 588
>12 4 1.6 0 0 18 9.3
Delivery mode, %
Vaginal 217 84.1 148 78.3 116 59.8
C-section 37 14.3 26 13.8 74 38.1
Missing 4 1.6 15 7.9 4 2.1
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the critical period for overweight and obesity develop-
ment must be identified.
Previous studies have identified the first 3 months of
life as a critical period when infant growth is mainly nu-
trition dependent [14]. In this study we investigated the
association between the effect of early infant feeding
practices on growth velocity in the first 6 months, and
the effect of 12 week infant feeding and 12–24 week
growth velocity on BMI-for-age Z-score at 2 years of age
amongst HIV unexposed children.
The proportion of overweight and obese children in
our sample was high considering that recent findings from
the first South African National Health and Nutrition
Examination Survey (SANHANES-1) indicate a preva-
lence of overweight (BMI: 25–29.9) and obesity (BMI >30)
of 17.5%(95% CI 11.4,23.6%) and 4.4%(95% CI 2.2,6.5%)
respectively among boys aged 2–5 years; 18.9%(95% CI
14.1,23.4%) and 4.9%(95% CI 2.9,7.0%) among girls [42].
Consistent with results from Chirwa et.al. [43], our
study found higher weight velocity in the first few
Table 2 Food consumption at 3, 12 and 24 weeks based on 24-hour and 7-day recall
3 week feeding 12 week feeding 24 week feeding
(N = 629) (N = 629) (N = 629)
n % n % n %
Breast milk
Yes 527 89.3* 458 79.4* 395 67.4*
Water
Yes 269 42.8 264 45.8* 358 61.1*
Sugar water
Yes 189 30.05 286 49.6* 154 26.3*
Traditional herbs
Yes 424 67.4 167 28.9* 155 26.5*
Commercial infant formula
Yes 305 48.5 363 62.9* 366 62.5*
Cereals
Yes 180 28.6 366 63.4* 527 89.9*
Fruits/vegetables
Yes 66 10.5 168 29.1* 400 68.3*
Prescribed medicines
Yes 260 41.4* 231 89.5* 289 100.0*
Non-prescribed medicines
Yes 444 70.6 355/577 61.5* 258 44.0*
*Percentage calculations were based on the total number of available data for each food item. The denominator was 629 unless otherwise indicated by
the asterisk.
Table 3 Period-1 (the 3/6 week–12 week) and period-2 (12–24 weeks) mean weight velocity (WVZ) and length velocity
(LVZ) by infant feeding1
3 week feeding
Period 1: 3/6–12 weeks Never breastfed Breastfed3
n Mean ± SD n mean ± SD P-value2
WVZP1 (N = 522) 60 1.58 ± 1.72 462 0.99 ± 1.60 <0.01
LVZP1 (N = 402) 46 1.69 ± 2.62 356 1.37 ± 2.44 0.41
12 week feeding
Period 2: 12–24 weeks Never breastfed Breastfed3 P-value2
WVZP2 (N = 494) 98 1.07 ± 1.75 394 0.64 ± 1.57 0.02
LVZP2 (N = 477) 93 0.82 ± 2.62 382 0.85 ± 2.52 0.93
1Values are mean ± SD of velocity Z-scores based on WHO standard. LVZ, length velocity Z-score; P1, Period-1; P2, Period-2; WVZ, weight velocity Z-score.
2Student test P values for group comparisons a 5% significance level.
3Children received breast milk in addition to other solids and liquids.
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months of life to be strongly associated with higher
BMI-for-age Z-score at 2 years. We also demonstrated
that children who were not breastfed at 12 weeks had
higher mean WVZ between 12 and 24 weeks, higher
BMI-for-age Z-scores at 2 years and were more likely to
be overweight/obese. This suggests that the protective
effect of breastfeeding against childhood obesity risk is
partly based on its mediating effect on infant weight vel-
ocity. The higher BMI-for-age Z-scores in non-breastfed
children could partly be attributed to their earlier intro-
duction to nutrient dense cereals and formula which
may have led to the rapid weight gain observed in the
first 6 months of life; consistent with previous systematic
reviews [44-46].
Commercial infant formulae, such as the NAN Pelargon®
that was commonly used in South Africa at the time of
the study, also have higher protein content (14 g/day) [47]
compared to breast milk (9 g/day) [48] around 3 months.
A high protein intake in excess of metabolic requirements
stimulates the secretion of insulin and insulin growth fac-
tor 1 (IGF-1) axis and subsequently increases weight gain
in infancy [25,49] through heightened cell proliferation
and adipogenic activity (adipocyte differentiation) [50]. In-
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Figure 2 Univariate density distribution of the sample BMI-for-age Z-scores at 2 years (blue distribution) and a normal reference
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Figure 3 2 year BMI-for-age Z-score estimated density distributions with regards to 12 week breastfeeding status. The vertical red
reference line indicates the +2 BMI-for-age Z-score threshold which corresponds with overweight status.
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formula fed infants compared to breastfed infants [51].
Based on this “early protein hypothesis”[50] Koletzko and
colleagues [25] conducted a randomized clinical trial that
assessed whether growth differed between breastfed chil-
dren and those fed a low protein (1.77 g/100 Kcal) formula
before 6 months. Their results showed no significant
difference in mean BMI and obesity risk between these
two groups from 3 months of age until 6 years [25]. None-
theless, exclusive breastfeeding continues to be strongly
recommended as it has many other advantages, such as
protection against gastrointestinal infections [52], which
are particularly important in resource limited settings
where formula feeding may not be acceptable, feasible,
affordable, sustainable and safe. Breast milk also has a
lower average caloric density (kcal/100 mL) [53] compared
to infant formula, and the energy per kg of bodyweight in
breastfed infants is 10–18% lower than for formula fed in-
fants aged between 3 and 12 months [50]. Furthermore
evidence shows that breastfed infants self-regulate the
quantity and frequency of milk intake better than
formula-fed infants, who tend to empty their bottles [54].
Formula-fed infants are also twice as likely to complete
their meals later in infancy, even when satiated, compared
to breastfed infants [55]. While cereals were given more
frequently to formula-fed infants in this study, early intro-
duction of solids was also highly practiced in breastfed in-
fants. This early introduction of cereals could have
displaced some of the breastfeeding and may therefore
partially explain the higher BMI-Z-scores observed in the
sample breastfed infants compared to the international
reference. Previous observational studies showed that chil-
dren introduced to complementary foods earlier than 3 or
4 months, compared with later introduction, were more
likely to be overweight or obese [21,24,56]. Collectively,
these results indicate that any breastfeeding in the first
3 months of life is protective against rapid weight gain in
infancy and therefore plausibly protects against subse-
quent later overweight/obesity [18,36,57,58]. This further
highlights the importance of early infant feeding as a key
intervention to prevent childhood overweight/obesity. It
is therefore of serious concern that amongst this group of
HIV unexposed children, approximately half had been in-
troduced to commercial infant formula milk by the age of
three weeks. The decade of provision of free commercial
infant formula milk at clinics through the Prevention of
Mother to Child Transmission of HIV (PMTCT) services,
together with the absence of a clear message to mothers
regarding infant feeding has likely contributed to this
situation [59]. Enormous efforts, detailed in the revised
2013 Infant and Young Child Feeding Policy which
unambiguously supports breastfeeding as the optimal
feeding mode for infants, are required to improve the
EBF prevalence in South Africa [60]. Changing practices
however takes time and will require collective action
from all stakeholders, including communities and
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1Values are ordinary least square (OLS) and quantile regression beta-coefficients (adjusted for birth weight, weight velocity between 12–24 weeks, 12 week
BMI-for-age Z-score, maternal education, study site and intervention arm) with respective 95% confidence intervals in brackets. 466 observations were assessed in
the models. With the exception of study arm, only variables that had significant association with BMI-for-age Z-score in the bivariate analysis were included in the
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Figure 4 Quantile regression and ordinary least squares (OLS)
coefficients. The figure presents the never breastfed coefficients
from the final model for the 10th,20th,30th,40th, 50th, 60th,70th, 80th
and 90th 2 year BMI-for-age Z-score quantiles. The respective values
are connected by the maroon solid line with accompanying
estimated 95% confidence interval intervals shaded in grey. The OLS
value is depicted by the horizontal blue line with 95% confidence
limits depicted by the black dotted lines.
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healthcare workers. Interventions to support breastfeed-
ing in the workplace are also critical [61].
Our study has several strengths. To our knowledge this
is the first study to assess the effect of early infant feeding
on childhood BMI in African children [18,36,57,58].We are
also not aware of any previous studies that have examined
the effect of early weight velocity on later BMI using the
WHO growth standards in this population group. We used
simultaneous quantile regression, a more detailed tech-
nique than OLS regression, to examine the effect of weight
velocity and infant feeding across the BMI-for-age Z-score
distribution. As with Beyerlain and colleagues [62], this
statistical approach enabled us to observe the differential
effect of breastfeeding, which was not detected by OLS re-
gression, on the upper tail of the conditional BMI-for-age
Z-score distribution at 2 years.
Limitations of the present study were the absence of
data on maternal nutritional status and smoking during
pregnancy, which are known determinants of infant weight
velocity and childhood overweight/obesity [63,64]. In this
study we used maternal HIV status reported at recruitment;
this information is subject to bias. We only included those
women that reported being HIV negative in this paper;
some women may have seroconverted during the follow-up
period and would therefore be misclassified. The small
group of HIV positive women and their children was ex-
cluded from this analysis because 1) infant HIV test results
were not obtainable for one of the study sites and 2) rele-
vant data to adjust for in this group (e.g. viral load, CD4
count and detailed information on antiretroviral (ARV)
drug use) were not available. Birth weights were used to es-
timate the period-1 velocity for only 15 children (2.34% of
the analysed sample) that did not have 3 week weight data.
We therefore do not think that this small proportion of the
sample skewed the results. Our feeding exposure variable
was based on short term reporting of feeding practices, and
not on a longitudinal assessment of feeding, at the assumed
time of 12 weeks. Recall bias together with lack of precise
information on the timing of the consumption of each food
item and the exact quantities consumed may have therefore
introduced variability in the data that is evidenced by wide
confidence intervals observed in infant feeding quantile
regression estimates. Furthermore, data were missing for
some of the food variables because participants did not re-
spond when asked about the consumption of that particular
food item. There was also overlap between the confidence
intervals of the OLS and quantile regression models and
this may largely be due to the relatively modest sample size
we used for this analyses approach (n = 466) compared to
other studies [36,62,65].
Conclusion
This study demonstrates that infant feeding practices in
the first 12 weeks of life can predict the development of
childhood overweight and obesity. Early life therefore
presents a crucial window of opportunity for interven-
tions to address modifiable factors such as infant feeding
practices in order to reduce the risks of rapid weight
gain in infancy and subsequent childhood overweight/
obesity.
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PhD paper I Erratum
The data cleaning section of Paper I had a few errors that needed to be corrected. The data 
cleaning section will be replaced with the following text which has been submitted to the 
International Journal of Breastfeeding:
“Anthropometric measurement values and Z-scores were flagged for verification if any of the 
following criteria were met: WAZ<-6 or >5, WLZ<-5 or >5, LAZ<-6 or >6, WLZ>3 and 
LAZ<-3; 2) extreme changes in LAZ and WLZ (greater than 2.5 or 3) between consecutive 
visits; 3) BMI-for-age Z-
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Despite the recognised benefit of antiretroviral therapy (ART) for preventing and treating HIV; 12 
some studies have reported adverse birth outcomes with in-utero ART exposure. We evaluated 13 
the effect of infant in-utero HIV and ART exposure on preterm delivery (PTD), low birth 14 
weight (LBW), small-for-gestational age (SGA) and underweight-for-age (UFA) at six-weeks.15 
Methods16 
We surveyed 6179 HIV-unexposed-uninfected (HUU) and 2599 HIV-exposed-uninfected 17 
(HEU) infants. HEU infants were stratified into three groups: ART; Zidovudine alone; no 18 
antiretrovirals (None). The ART group was further stratified to explore pre- or post-conception 19 
exposure. Multivariable logistic regression evaluated effects of HIV and ARV exposure on the20 
outcomes.21 
Results: We found higher odds of PTD, LBW, SGA and UFA in HEU than HUU infants. HEU22 
in the None group (adjusted odds ratio [AOR], 1.9; 95% CI, 1.2, 3.0) or those whose mothers 23 
initiated ART pre-conceptually (AOR, 1.7; 1.1, 2.5) had almost twice the odds of PTD than 24 
infants whose mothers started ART post-conceptually, but no increased odds for other 25 
outcomes.26 
                                                             
2Funding support: This paper was supported by funding from the South African National Health Scholarship 
Programme and CDC. The content presented here is the responsibility of the authors  and does not necessarily 
represent the official views of the South African National Health Scholarship Programme and CDC. Presented in 
part: 6th African Nutritional Epidemiology Conference, Accra, Ghana, 21-25 July 2014. Correspondence: Vundli 
Ramokolo, South African Medical Research Unit, Health Systems Research Unit, South Africa, 
vundli.ramokolo@mrc.ac.za; vundli.ramokolo@uib.no; +27 21 938 0549 (tel) 
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Conclusions: ART resulted in better birth outcomes, however, there was an association 27 
between pre-conception ART and PTD. As ART access increases, pregnancy registers or 28 
similar surveillance should be in place to monitor outcomes to inform future policy.29 





With the success of the prevention of mother to child HIV transmission (PMTCT) programme, 33 
HIV-exposed-uninfected (HEU) children now constitute the majority of the children affected 34 
by the HIV pandemic [1]. In January 2015 South Africa (SA), which has a maternal HIV 35 
prevalence of 29%, adopted the 2013 World Health Organization (WHO) recommendation of 36 
lifelong antiretroviral treatment (ART) for all HIV-positive pregnant women, referred to as 37 
WHO-PMTCT Option-B+, as a PMTCT strategy and to maintain maternal health [2, 3].38 
Although the benefits of ART outweighs the potential adverse effects, this population of HEU 39 
children requires monitoring to better understand the short and long term health effects of HIV 40 
and ART exposure [4]. The shift to Option-B+, and the possible future use of pre-exposure 41 
prophylaxis (PreP) as a primary prevention method in HIV-uninfected adolescents and young42 
women [5, 6], will increase the number of children exposed to ART during critical intrauterine, 43 
intrapartum and postpartum periods. It is well established that HIV infection in children is 44 
associated with poor birth [7] and postnatal [8-10] outcomes. However the effect of exposure 45 
to maternal HIV infection and ART use on the birth outcomes of HEU infants in resource-46 
limited settings, where HEU children have a higher mortality risk than HUU children [11], and 47 
where endemic under-nutrition and co-infections can compound any potential adverse effect 48 
of HIV or ART exposure, is less clear. Using data from a nationally representative facility-49 
based PMTCT survey we studied the effect of infant in-utero HIV and ART exposure on 50 
preterm delivery (PTD), low birth weight (LBW) and small-for-gestational age (SGA) at birth,51 







Study design 56 
The 2012-13 South African PMTCT Evaluation (SAPMTCTE) was a nationally representative 57 
facility-based cross-sectional survey, conducted between October 2012 and May 2013, to 58 
measure vertical HIV transmission at 4-8 weeks postpartum. During this study, ART use was 59 
criteria-led (WHO PMTCT ‘Option-A’), changing to ‘universal test and treat’ for all HIV-60 
positive pregnant women throughout breastfeeding (‘Option-B’) in April 2013. Under Option-61 
A, antiretroviral drug (ARV) naïve HIV-infected pregnant women were placed on ART62 
(recommended tenofovir disoproxil fumarate (TDF) + Lamivudine (3TC/FTC) + Nevirapine63 
(NVP)) 3and Zidovudine (ZDV) from 14 weeks gestation, 64 
(with infant NVP for six weeks or until one week post-breastfeeding) if CD4 >350 65 
cells/mm3 [12].66 
The study methods have been described elsewhere ([13] and supplementary materials). In brief,67 
580 primary health facilities offering immunisation services were sampled using a probability 68 
proportional to size approach. Consenting mother-infant pairs, attending immunisation 69 
services, were consecutively or systematically enrolled, regardless of maternal HIV status, in 70 




Maternal HIV infection and ART use were the primary exposures. Trained nurse data collectors 75 
drew infant dried blood spot (iDBS) specimens during the study visits. All iDBS received HIV 76 
antibody (serological) testing and, antibody-positive samples or samples from self-reporting 77 
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HIV-positive mothers, were tested for both HIV-1 proviral DNA and HIV-1 RNA (see 78 
supplementary methods). Data collectors used electronic questionnaires to gather data on the 79 
mother’s self-reported ARV drug use and timing of initiation. As no maternal blood specimens 80 
were collected, a mother was defined as HIV-negative if the infant’s antibody result was 81 
negative, and HIV-infected if two infant HIV antibody test results were positive. An infant was 82 
defined as HEU if (i) the HIV antibody result was positive and PCR result was negative, or (ii) 83 
the antibody result was positive and PCR equivocal or rejected (1% of sample), or HUU if both 84 
results were negative. Amongst HIV-infected mothers, self-reported ARV use was categorised 85 
into three groups: namely (i) ART-use primarily for mother’s health (ART-group), as per 86 
Option-A guidelines, (ii) antenatal ZDV as MTCT prophylaxis (ZDV-group) and (iii) no ARV 87 
use antenatally (None-group). Given that ART, particularly TDF which has been associated 88 
with poor birth outcomes, has low bioavailability in breastmilk [14], infants whose mother’s 89 
only started ART postnatally were excluded from this analysis. In an effort to (i) make the 90 
periods of exposure to ARV drugs comparable between women on ZDV vesrsus ART and (ii) 91 
compare outcomes by duration of ART exposure, women on ART were further dichotomised 92 
by ART duration and those who initiated ART post-conception treated as the reference.93 
94 
Outcomes 95 
The outcomes of interest were PTD, LBW, SGA at birth, and UFA at 6 weeks postpartum.96 
Birth weight and length, 6-week weight and length, and gestational age were extracted from 97 
the infants’ routine road to health booklets at 4-8 weeks (median 6 weeks) postpartum. The 98 
anthropometric measurements were conducted by routine health facility staff using facility99 
procedures and equipment. Length data were excluded in this analysis due to measurement 100 
errors and missing data. Health facility staff routinely estimated infant gestational age at 101 
delivery using the last menstrual period (LMP). PTD was defined as birth before 37 completed 102 
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weeks gestation, LBW as birthweight <2.5Kg, and SGA as birthweight-for-gestational-age Z-103 
score below -1.28 (equivalent to <10th percentile)[15, 16]. We estimated birthweight-for-104 
gestational-age Z-scores using recently published international Intergrowth-21st standards for 105 
assessing new born size for term and pre-term born infants [17] and LMS growth [18]. We 106 
estimated weight-for-age Z-scores (WAZ) in infants aged 4-8 weeks using the WHO growth 107 
standards [19] and considered infants as UFA if their WAZ was below -2 [20].108 
109 
Data cleaning110 
Anthropometric measurements and Z-scores were flagged for verification if any of the 111 
following criteria were met: birthweight-for-gestational Z-score <-6 or >6; WAZ less than -6112 
or >5. Except for gestational age, which had 1% observations set to missing after verification113 
(including 3 gestational ages outside of the range for the Intergrowth standards (20-23 weeks)),114 
the remaining measurements and Z-scores had <1% observations omitted.115 
116 
Covariates 117 
Covariates in the models were selected a priori based on literature [21] and a conceptual 118 
framework (supplementary Figure 1). Participants were defined as food insecure if they ever 119 
ran out of food in the previous year. Multiple correspondence analysis (MCA) was used to to 120 
construct the socio-economic status (SES) index (see supplementary materials). Infant feeding 121 
practices were established through 24-hour and 7-day day recall infant feeding questions and122 
infants were categorised into two groups: 1) ‘breastfed’ if they received any breastmilk and 2) 123 
‘none-breastfed’ if they received no breastmilk. As SA has racial inequalities, race was 124 
included in the models as a potential social determinant of the study outcomes [22]. Based on 125 
the reported race, study infants were classified as: 1) “black”, 2) “coloured”, a multiracial group 126 
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Analyses were survey based and additional weighting for missing gestational age data was 131 
applied to the PTD and SGA analyses (see supplementary materials). Categorical variables 132 
were compared using the Pearson chi-squared test while linear regression was used to test 133 
equality of means. The Wald test was used for multiple hypothesis testing. In the modelling we 134 
first generated four multivariable logistic regression models to assess the effect of in-utero HIV 135 
exposure on the outcomes in the total sample of HUU and HEU infants. We then restricted the 136 
analysis to HEU infants and compared the outcomes by ART exposure status and duration137 
using four additional models. To avoid bias introduced by adjustment of potential mediators in 138 
the presence of unmeasured common causes, the “LBW paradox” [23], variables such as 139 
birthweight were not included in the UFA models. In each full model we also included 140 
interaction terms to test whether infant HIV exposure modifies the effect of other covariates on 141 
birth outcomes. Statistical analyses were performed at a 5% significance level using STATA-142 
14 (Stata Corp., College Station, Texas, USA, 2007), R Software-3.1.2 and IBM-SPSS 143 
Statistics-22 (SPSS Inc, Chicago, IL, USA).144 
Ethical considerations145 
Ethical approval was obtained from the South African Medical Research Council and the 146 
Office of Associate Director of Science at the United States Centers for Disease Control and 147 




There were 9119 live born infants in the SAPMCTE study of which 8976 were of a singleton 151 
birth (Figure 1). The final sample analysed included 6179 HUU and 2599 HEU infants after 152 
some exclusions. Notably, women who initiated ART pre-conception were older, had a higher 153 
parity, and higher frequencies of TB and syphilis than women in the other ARV groups (Table 154 
1). 155 
Prevalence of PTD, LBW, SGA and 6 weeks childhood underweight156 
The prevalences (95% confidence intervals [CI]) of PTD, LBW and SGA were 12.5% (11.4%; 157 
13.7%), 10.7% (10.0%; 11.5%), and 14.9% (13.8%; 16.1%) respectively in the total sample158 
(Table 2). The prevalence of PTD was similar between HUU (12.3% (11.1%; 13.7%)) and 159 
HEU (12.9% (11.12%; 14.7%)) infants (P=0.59) in the unadjusted analysis, whereas the latter 160 
group had a higher prevalence of LBW (13.0% vs 9.8%, P<0.01) and SGA (16.9% vs 14.0%, 161 
P=0.03). UFA at 6 weeks postpartum was observed in 9.2% (8.6%; 10.0%) of the total sample. 162 
A higher proportion of infants were underweight in HEU (11.0%) versus HUU (8.4%) infants 163 
(P<0.01). 164 
Factors related to PTD, LBW and SGA165 
Multivariable analyses demonstrated a higher odds of PTD if the infant was HEU versus HUU 166 
(adjusted odds ration (aOR), 97% CI: 1.2 (1.0; 1.5)), was of coloured versus black race (1.7 167 
(1.3; 2.3)), was born to a mother wth less than a secondary education (1.4 (1.1; 1.7) and resided 168 
in a poorer household (1.7(1.2; 2.5)). There was a reduced odds of PTD if the infant was born 169 
to a mother aged 30-35 versus <20 years (0.7 (0.5; 0.9)) and had more than 5 antenatal care 170 
(ANC) visits versus 5 (0.7 (0.6; 0.9)) (Table 3). Within the HEU sub-group, infants in the 171 
None-group (1.9 (1.1; 3.1)) or those whose mothers initiated ART pre-conception (1.7 (1.1; 172 
10 
2.5)) had almost twice the odds of PTD than infants whose mothers initiated ART post-173 
conception. 174 
A higher odds of LBW was observed if an infant was HEU versus HUU (1.6 (1.3; 1.9)), born 175 
to a mother with TB during pregnancy (1.6 (1.1; 2.5)) and if the infant was of coloured versus 176 
black race (2.0 (1.5; 2.6)) was born to a mother wth less than a secondary education (1.3 (1.0; 177 
1.6) and resided in a poorer household (1.5(1.1; 2.0)); a reduced odds of LBW if the infant was178 
born to an older mother versus a mother aged <20 years (0.6 (0.5; 0.8)), a mother who had 179 
more than 5 versus 5 ANC visits ( 0.8 (0.6; 0.9)) or if the infant was male versus female (0.8 180 
(0.7; 0.9)) (Table 4). 181 
A higher odds of SGA was observed if an infant was HEU versus HUU (1.3 (1.1; 1.6)) and 182 
born of coloured versus black race (1.6 (1.3; 2.0)). Factors protective against SGA were older 183 
maternal age (aged 26-29) versus aged <20 years ( 0.6 (0.4; 0.8)) and attendance of 5 versus184 
5 ANC visits (0.8 (0.7; 1.0)) (Table 5). 185 
Factors related to UFA at six weeks postpartum186 
A greater odds of UFA at 6 weeks postpartum was observed if an infant was HEU versus HUU187 
(1.5 (1.2; 1.8)) , of coloured versus black race (2.2 (1.6; 2.8)), was born by C-section versus 188 
vaginal delivery (1.4 (1.1; 1.7)) , had experienced diarrheal episodes (1.9 (1.3; 2.8)), was born 189 
to mother who had TB during pregnancy (1.8 (1.2; 2.8)) or had less than a secondary education 190 
(1.4 (1.1; 1.8) and resided in a poorer household (1.5(1.1; 2.0)). A reduced odds of underweight 191 
was observed if the infant was breastfed versus not breastfed (0.8 (0.6; 1.0) and if the infant 192 
was born to a mother who attended more than 5 ANC visits versus (0.8 (0.6; 1.0)) (Table 193 
6). None of the models showed evidence of effect measure modification by HIV exposure 194 




In a nationally representative survey we observed a greater odds of PTD, LBW, SGA and 198 
underweight among HEU than HUU infants. 199 
We noted that HEU infants whose mothers did not receive any ARV drugs carried higher odds 200 
of PTD than ART exposed infants but no increased odds for LBW, SGA and underweight. In 201 
addition, among ART exposed pregnancies, PTD was more common among infants whose 202 
mothers initiated ART pre-conception than postconception. We also identified several 203 
independent risk factors for poor birth and growth outcomes, including coloured race, which 204 
was associated with all study outcomes; birth by C-section, was associated with UFA; exposure 205 
to maternal TB during pregnancy was associated with LBW and UFA and diarrhea was a risk 206 
factor for UFA; a lower maternal education and household SES, which were associated with 207 
PTD, LBW and UFA. Factors that were protective against all outcomes included older maternal 208 
age and more frequent ANC attendance. Additonal protective factors included male gender for 209 
LBW and UFA and breastfeeding for UFA.210 
Our finding that HEU infants have more adverse birth outcomes than HUU infants has been 211 
reported in other African studies ([24] supplementaty Table 2). Within SA, data from a212 
hospital-based cohort study in the Western Cape showed a higher prevalence of PTD and LBW,213 
but not SGA, in HIV-exposed versus HUU infants [25]. Surveillance pregnancy registry data 214 
in KwaZulu-Natal also showed a higher prevalence of LBW in HIV-exposed than HUU 215 
infants[26]. Another cohort study in the same region reported a higher prevalence of SGA but 216 
not PTD in HIV-exposed infants [7]. The mechanisms through which maternal HIV infection 217 
results in specific adverse birth outcomes in HEU infants are still unclear. Current evidence 218 
suggests that HIV exposure elicits chronic immune activation and systemic inflammation in 219 
HEU infants [27, 28], particularly in infants born to women with higher viral loads [29], which220 
12 
has been associated with PTD [30, 31] and LBW [31]. These proposed mechanisms may partly 221 
explain why, similar to other studies [32, 33], our study infants born to women with untreated 222 
HIV infection had higher rates of PTD compared to infants born to women who initiated ART223 
during pregnancy. These results support the current “test and treat” strategy of initiating all 224 
newly diagnosed HIV-positive pregnant women on ART. 225 
However, exposure to ART during pregnancy, a critical period of foetal growth and 226 
development, may carry some risks. Evidence on the effect of in-utero ART exposure on 227 
adverse outcomes is mixed ([34] and supplementary Table 2), and there is still uncertainty228 
whether observed adverse effects are specific to particular drugs or combinations thereof. 229 
Moreover as more countries adopt the Option-B+ strategy, many more women will be on ART230 
drugs at conception, highlighting the importance of setting up pregnancy registers or similar 231 
surveillance systems to monitor whether earlier ART initiation adversely affects  birth 232 
outcomes in order to inform future policy. Such monitoring fits into the broader child health 233 
goals of reducing child mortality while optimising good health and well-being [35]. Consistent 234 
with findings from a recent review [36], our data shows that PTD is higher amongst women 235 
who initiated ART pre-conception than amongst mothers initiating ART post-conception.236 
These findings are in contrast to the null associations reported in single-site hospital based 237 
retropective [37] and prospective[25] cohort studies conducted in SA and could be biased by 238 
the unmeasured maternal disease severity or could be due to selection bias[38]. In line with 239 
these studies, however, LBW and SGA did not differ by timing of ART initiation in our sample. 240 
The success of PMTCT programmes make it possible for most HIV-exposed infants to remain 241 
uninfected [1]. Therefore, while the proportion of under-five deaths attributed to HIV infection 242 
has decreased in SA, the proportion of under-5 deaths due to neonatal conditions, which 243 
contribute the most to under-five mortality, has increased. Given that PTD complications 244 
constitute the bulk of these neonatal conditions, it is important that risk factors of PTD are 245 
13 
addressed through better care of both mothers and infants [39, 40]. Our findings that older 246 
maternal age and more frequent ANC visits were protective against all adverse study outcomes, 247 
and that infants born to women with lower maternal education and SES had a greater risk for 248 
PTD, LBW and UFA, highlight the importance of health system strengthening and the need for 249 
further investment in multi-sectoral “nutrition-sensitive” interventions [41] that address the 250 
multifactorial etiology of these outcomes. The protective effect of breastfeeding on childhood251 
underweight further emphasises the importance of supporting early initiation of breastfeeding 252 
for all infants. 253 
Our study describes birth outcomes in infants that survived their first month of life, therefore, 254 
our overall LBW rate is lower than the national estimate of 14.8%, which is based on data from 255 
all live births [42]. Background national estimates of PTD and SGA are not readily available. 256 
Our PTD rate was higher than the 8.0% modelled by Blencowe, et al. [43] based on data from257 
two hospital-based studies, while our SGA rate is lower than 23% and 21.8% reported by Lee, 258 
et al. [44] among preterm and term born infants respectively.259 
This study has some limitations. First, we were limited by the lack of key clinical data, such as 260 
maternal obstetric history, substance use, accurate CD4 cell count, HIV viral load and whether 261 
or not the PTD was induced or spontaneous. While data collectors used a chart to assist HIV-262 
infected mothers recall their self-reported ARV-drug use, which is subject to recall bias and 263 
may cause misclassification of participants, the lack of detailed information on the specific 264 
drug and dose used precluded the extent to which study outcomes could be assessed by ART265 
regimen. However, data does show there is no significant difference in PTD between infants 266 
exposed to TDF-containing ART and other combinations [45] although a greater risk of PTD 267 
has been reported with protein-inhibitor compared to nucleoside-reverse-transcriptase-based 268 
ART [46, 47]. Furthermore, some women initiated on ART pre-cenception may have been on 269 
different ART regimens, probably second-line treatment due to drug resistance or poor 270 
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adhenrance, than women started post-concepton. Although self-reported CD4 cell count data 271 
were also available, we did not include them in the final analysis as the exact timing of the 272 
CD4 count testing was unknown, many mothers did not know their results and those who had 273 
the information only reported one result. The lack of CD4 count and viral load data precluded 274 
the extent to which the effect of maternal immune suppression and viremia respectively, could 275 
be assessed. We also could not stratify the ARV analyses by CD4 categories in order to 276 
minimize bias by indication. Secondly, as this was an observational study we could not 277 
establish causal relationships. Nevertheless in an effort to minimize bias we included, based on 278 
a conceptual framework, factors known to influence our outcomes in the multivariable 279 
analyses. Thirdly, we obtained gestational age from the infant’s health card, which contained280 
LMP-based gestational age data. Whilst this method remains the most commonly used method 281 
in SA, it has several limitations including poor recall of the date of LMP and a tendancy to over 282 
estimate PTD [48]. However, evidence suggests that LMP is a fairly reliable measure of 283 
gestational age in resource limted settings [49]. We also used routinely collected infant weight 284 
data which are subject to measurement error. Fourthly, in accordance with the 2010 WHO 285 
PMTCT guidelines, HIV-positive pregnant women that were not eligible for ART were started 286 
on ZDV from 14 weeks gestation to ensure sufficient drug exposure time by late pregnancy 287 
[50] as this period carries the highest risk of MTCT [51]. Eligible HIV-positive pregnant 288 
women were however started on ART immediately in order to improve maternal health and 289 
reduce MTCT. We were therefore concerned about potential lead time bias when comparing 290 
the outcomes of the ZDV versus ART HEU infants. Although an analysis of our data revealed 291 
that the time of exposure to the drugs was similar between the ARV groups we restricted the 292 
ZDV versus ART comparisons to women who initiated ART post-conception to minimize this 293 
bias. Lastly, selection bias is possible as sick infants needing emergency care, infants that died 294 
before the 6-week clinic visit and infants attending small remote  facilities were excluded. As 295 
15 
 
these infants represent particularly vulnerable groups our estimates of LBW, SGA, PTD and 296 
UFA could be underestimated.  297 
Notwithstanding these, our study has some strengths. Firstly, this is the largest nationally 298 
representitve study of birth outcomes and growth to date among HEU and HUU infants in SA,299 
although it has inherent cross-sectional study limitations related to temporality. Secondly, the 300 
availability of laboratory HIV-1 ELISA and PCR results enabled us to exclude HIV-infected 301 
infants from the analyses, although NVP exposure may cause false-negative results[52].302 
Thirdly, we collected data, although not exhaustive, on maternal, infant and health system 303 
characteristics which enabled us to explore the independent effect of these factors and adjust 304 
for them as potential confounders. Fourthly, we estimated birthweight-for-gestational age Z-305 
scores using the recent Intergrowth standard for term and pretern born infants. Lastly, we306 
collected data before the wide-scale implementation of Option-B+ in SA, which enabled us to 307 
compare outcomes of in-utero ZDV exposed versus ART-exposed infants. 308 
In conclusion, ART resulted in better birth outcomes, however, there was an association 309 
between pre-conception ART and PTD. As ART access increases, pregnancy registers or 310 
similar routine surveillance should be in place to monitor outcomes to inform future policy.311 
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Note: gestational age; GA 
9880 (93.8%) Eligible 
9679 (98.0%) Caregiver consented 
9631 (99.50%) Interviewed + iDBS consent 
10533 Screened 
652 (6.2%) Not eligible 
184: Missing info on consent & DTP 
132: Child needed emergency care 
136: Child <4wks or >8wks 
200:  Child did not receive DTP  
201 (2.0%) Refusals 
47 (0.48%) Mother refused DBS 
9201 (95.53%) Interview+ iDBS available 
9119 (99.11%) Interview+ iDBS available  
2876 ELISA positive 
430 (4.5%) No iDBS result available 
383: Specimen lost in transit 
21: Insufficient specimen not sent to lab 
26: Blood specimen not taken 
70 (0.8%) iDBS  Rejected by lab 
6243 ELISA negative 
Figure 1: SAPMTCTE study profile 
Birth weight: 2531 GA: 1845 Birth weight: 6042 GA: 4380 
Excluded:  
80 Multiple births  
67 HIV infected infants 
31 infants-mum started ART postpartum 
99 infants with no ARV information 
Excluded:        
64 Multiple births  
6week weight: 2443 6week weight: 5842 6 week WAZ: 2440 6 week WAZ: 5842 
2599 singleton HEU infants 6179 singleton HUU infants 
Birth Z-score: 1819 Birth Z-score: 4333 




























































































   

















   





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 3: Weighted multivariable logistic regression models for factors related to
preterm delivery (PTD) in A) HIV exposed uninfected and HIV unexposed uninfected 
infants and B) HIV exposed uninfected infantsa
Variable                                        A) HEU and 
HUUb combined
B) HEU only c
AOR 
(95%CI)




   HEU 1.2 (1.0; 
1.5)
0.04 ---- ----
   HUU Ref
ARV ---- 0.04*
   Pre-conception ART 1.7 (1.1; 
2.5)
0.02
   ZDV 1.4 (0.9; 
2.0)
0.11
   None 1.9 (1.1;
3.1)
0.01
   Post-conception ART Ref 
Syphilis serology









0.65 1.1 (0.5; 
2.3) 
0.83
No Ref Ref 
Maternal age 0.08* 0.08*




















<20 Ref Ref  
Parity 0.20* 0.08*





4+ 0.9 (0.6; 
1.2) 
0.40 0.7 (0.4; 
1.2) 
0.14
1 Ref Ref 
Maternal education 
grade 7 1.4 (1.1; 
1.7) 
<0.01 1.1 (0.8; 
1.6) 
0.62




<0.01 0.7 (0.5; 
1.0) 
0.08
1-5 Ref Ref 
Household socio economic 
quintile 
<0.01* 0.02*
Poorest 1.7 (1.2; 
2.5) 
<0.01 3.0 (1.3; 
6.8) 
<0.01
Second 1.2 (0.9; 
1.7) 
0.26 1.7 (0.7; 
3.8) 
0.24
Third 1.3 (1.0; 
1.8) 
1.00 2.6 (1.2; 
5.9) 
0.02
Fourth 1.1 (0.8; 
1.5) 
0.68 2.1 (0.9; 
4.4) 
0.07
Least poor Ref Ref 
Household food insecurity
Yes 0.8 (0.6; 
1.0) 
0.07 1.0 (0.6; 
1.5) 
0.82
Table 4: Weighted multivariable logistic regression models for factors related to low birth 
weight (LBW) in A) HIV exposed uninfected and HIV unexposed uninfected infants and 
B) HIV exposed uninfected infantsa
No Ref Ref 
Infant race <0.01* 0.41*
Coloured 1.7 (1.3; 
2.3) 
<0.01 1.4 (0.7; 
2.7) 
Other 1.3 (0.5; 
3.4) 
0.56 ----
Black Ref Ref 
Infant gender 
Male 0.9 (0.8; 
1.0) 
0.12 1.1 (0.8; 
1.5) 
0.55
Female Ref Ref 
aThe values in the models are adjusted odds ratio, AOR (95%CI).  HEU, HIV exposed uninfected; 
HUU, HIV unexposed; Ref; Reference category. 
b Model included 6214 HIV exposed and unexposed infants. 
c Model included 1839 HIV exposed uninfected infants.
d Except for the asterisk below, the p-values in this table are t test p-values. The 5% significance 
level was used in all analyses
* This p-value is derived from the joint hypothesis testing adjusted Wald test







HEU 1.6 (1.3; 1.9) <0.01 ----
HUU Ref 
ARV ---- 0.27*
Pre-conception ART ---- 0.9 (0.6; 1.3) 0.54
ZDV 0.8 (0.6; 1.1) 0.14
None 1.1 (0.8; 1.6) 0.47
Post-conception ART Ref 
Syphilis serology
Positive 0.8 (0.5; 1.3) 0.29 0.6 (0.3; 1.2) 0.15
Negative Ref Ref 
Tuberculosis 
Yes 1.6 (1.0; 2.5) 0.03 1.3 (0.7; 2.6) 0.46
No Ref Ref 
Maternal age <0.01* 0.02*
20-25 0.8 (0.6; 1.0) 0.02 1.0 (0.5; 1.9) 0.95
26-29 0.6 (0.5; 0.8) <0.01 0.8 (0.4; 1.6) 0.59
30-35 0.6 (0.4; 0.8) <0.01 0.7 (0.4; 1.5) 0.38
>35 0.9 (0.6; 1.2) 0.49 1.5(0.7; 3.0) 0.28
<20 Ref Ref 
Parity 0.45* 0.40*
2-3 1.0 (0.8; 1.2) 0.87 0.9 (0.6; 1.2) 0.46
4+ 0.8 (0.6; 1.1) 0.23 0.7 (0.4; 1.2) 0.18
1 Ref Ref 
Maternal education 
grade 7 1.3 (1.0; 1.6) 0.03 1.0 (0.7; 1.4) 0.98
>grade 7 Ref Ref 
ANC visits
+5 0.8 (0.6; 0.9) 0.01 0.7 (0.5; 1.0) 0.07
1-5 Ref Ref 
Household socio economic 
quintile 
0.03* 0.43*
Poorest 1.1 (0.8; 1.5) 0.66 1.2 (0.6; 2.1) 0.66
Second 1.2 (0.9; 1.7) 0.20 1.1 (0.6; 2.1) 0.78
Third 1.5 (1.1; 2.0) 0.01 1.5 (0.8; 2.8) 0.22
Fourth 1.3 (0.9; 1.7) 0.16 1.4 (0.7;2.6) 0.34
Least poor Ref Ref 
Table 5: Weighted multivariable logistic regression models for factors related to small-
for-gestational age (SGA) in A) HIV exposed uninfected and HIV unexposed uninfected 
infants and B) HIV exposed uninfected infantsa 
Household food insecurity
Yes 1.1 (0.9; 1.4) 0.22 1.2 (0.9; 1.7) 0.27
No Ref Ref 
Infant race <0.01*
Coloured 2.0 (1.5; 2.6) <0.01 3.4 (1.8; 6.6) <0.01
Other 1.2 (0.5; 2.8) 0.67 ----
Black Ref Ref 
Infant gender 
Male 0.8 (0.7; 0.9) <0.01 0.8 (0.6; 1.0) 0.03
Female Ref 
aThe values in the models are adjusted odds ratio (95%CI).  Definitions: AOR, Adjusted odd ratio; 
HEU, HIV exposed uninfected; HUU, HIV unexposed; Ref; Reference category. 
b Model included 8476 HIV exposed and unexposed infants 
c Model included 2510 HEU infants. 
d Except for the asterisk below, the p-values in this table are t test p-values.  The 5% significance 
level was used in all analyses
* This p-value is derived from the joint hypothesis testing adjusted Wald test







   HEU 1.3 (1.1; 1.6) <0.01 ----
   HUU Ref
ARV ---- 0.14*
Pre-conception ART 0.9 (0.6; 1.3) 0.52
ZDV 0.7 (0.5; 1.0) 0.05
None 0.7 (0.4; 1.1) 0.08
Post-conception ART Ref
Syphilis serology
   Positive 1.3 (0.8; 2.3) 0.30 1.6 (0.9; 2.8) 0.15
   Negative Ref Ref 
Tuberculosis 
   Yes 1.3 (0.8; 2.1) 0.31 1.1 (0.6; 2.2) 0.76
   No Ref Ref 
Maternal age <0.01* 0.03*
   20-25 0.8 (0.6; 1.0) 0.10 0.8 (0.4; 1.5) 0.45
   26-29 0.6 (0.4; 0.8) <0.01 0.6 (0.3; 1.2) 0.17
30-35 0.7 (0.5; 1.0) 0.05 0.6 (0.3; 1.2) 0.15
>35 1.0 (0.7; 1.4) 0.91 1.2 (0.6; 2.5) 0.66
<20 Ref Ref 
Parity 0.67* 0.65*
2-3 0.9 (0.8; 1.1) 0.42 0.9 (0.7; 1.3) 0.64
4+ 0.9 (0.6; 1.2) 0.46 0.8 (0.5; 1.3) 0.36
1 Ref Ref 
Maternal education 
grade 7 1.1 (0.9; 1.4) 0.37 1.4 (1.0; 2.0) 0.04
>grade 7 Ref Ref 
ANC visits
+5 0.8 (0.7; 1.0) 0.02 0.9 (0.7; 1.3) 0.69
1-5 Ref Ref 
Household socio economic 
quintile 
0.35* 0.65*
Poorest 1.3 (1.0; 1.8) 0.09 1.3 (0.7; 2.3) 0.41
Second 1.4 (1.0; 1.9) 0.06 1.2 (0.6; 2.3) 0.60
Third 1.4(1.0; 1.9) 0.07 1.3 (0.6; 2.4) 0.52
Fourth 1.3 (0.9; 1.8) 0.14 1.0 (0.5; 1.9) 0.97
Least poor Ref Ref 
Household food insecurity
Yes 1.0 (0.8; 1.3) 0.87 0.8 (0.6; 1.2) 0.27
No Ref Ref 
Infant race <0.01*
Coloured 1.6 (1.3; 2.0) <0.01 2.1 (1.0; 4.4) 0.04
Other 1.5 (0.3; 7.4) 0.62 ----
Black Ref Ref 
Infant gender 
Male 1.0 (0.9; 1.2) 0.67 0.9 (0.7; 1.2) 0.60
Female Ref Ref 
a The values in the models are adjusted odds ratio (95%CI).  Definitions: AOR: Adjusted odd ratio; 
HEU, HIV exposed uninfected; HUU, HIV unexposed, Ref; Reference category. Only variables that 
had a significant association with low birth weight in the bivariate analysis were included the final 
multivariable models.
b Model included 6142 HIV exposed and unexposed infants. 
c Model included 1813 HIV exposed uninfected infants.
d Except for the asterisk below, the p-values in this table are t test p-values.  The 5% significance 
level was used in all analyses
* This p-value is derived from the joint hypothesis testing adjusted Wald test
Table 6: Weighted multivariable logistic regression models for factors related to
underweight-for-age (UFA) in A) HIV exposed uninfected and HIV unexposed uninfected 
infants and B) HIV exposed uninfected infantsa
Variable HEU and HUUb HEUc
AOR 
(95%CI)
p-valued AOR (95%CI) p-value
HIV exposure status ----
HEU 1.5 (1.2; 1.8) <0.01
HUU Ref
ARV 0.43*
Pre-conception ART ---- 1.1 (0.7; 1.6) 0.78
ZDV 1.1 (0.8; 1.6) 0.64
None 1.4 (0.9; 2.2) 0.12
Post-conception ART Ref 
Syphilis serology
Positive 0.7 (0.4; 1.1) 0.12 0.5 (0.3; 1.0) 0.05
Negative Ref Ref 
Tuberculosis 
Yes 1.8 (1.2; 2.8) <0.01 1.8 (1.0; 3.2) 0.04
No Ref Ref 
Maternal age 0.04* 0.15*
20-25 0.8 (0.6; 1.0) 0.06 0.8 (0.4; 1.4) 0.34
26-29 0.7 (0.5; 0.9) 0.01 0.7 (0.4; 1.3) 0.30
30-35 0.7 (0.5;0.9) 0.02 0.7 (0.4; 1.3) 0.21
>35 0.9 (0.6; 1.3) 0.48 1.1 (0.6; 2.2) 0.72
<20 Ref Ref 
Parity 0.33* 0.62*
2-3 0.9 (0.7; 1.1) 0.15 0.9 (0.6; 1.3) 0.52
4+ 0.8 (0.6; 1.2) 0.27 0.8 (0.4; 1.4) 0.33
1 Ref Ref 
Maternal education 
1.4 (1.1; 1.8) <0.01 1.20 (0.8; 1.7) 0.32
>7 Ref Ref 
ANC visits
+5 0.8 (0.6; 1.0) 0.02 0.9 (0.6; 1.2) 0.31
1-5 Ref Ref 
Household socio economic 
quintile 
0.01* 0.59*
Poorest 1.5 (1.1; 2.0) 0.02 1.4 (0.8; 2.7) 0.25
Second 1.2 (0.9; 1.7) 0.23 1.2 (0.6; 2.4) 0.58
Third 1.6 (1.2; 2.1) <0.01 1.6 (0.8; 2.9) 0.16
Fourth 1.2 (0.9; 1.6) 0.32 1.3 (0.7; 2.5) 0.38
Least poor Ref Ref 
Household food insecurity
Yes 1.2 (0.9; 1.5) 0.14 1.1 (0.8; 1.6) 0.63
No Ref Ref 
Delivery method
C-section 1.4 (1.1; 1.7) <0.01 1.4 (1.0; 1.9) 0.03
Vaginal Ref Ref 
Infant race <0.01*
Coloured 2.2 (1.6; 2.8) <0.01 2.6 (1.4; 5.0) <0.01
Other 1.3 (0.5; 3.5) 0.67 ----
Black Ref Ref Ref 
Infant gender 
Male 1.2 (1.0; 1.4) 0.04 1.4 (1.0; 1.8) 0.04
Female Ref Ref Ref 
Feeding 
Breastfed 0.8 (0.6; 1.0) 0.05 1.1 (0.8; 1.5) 0.56
None breastfed Ref Ref 
Diarrhoea 
Yes 1.9 (1.3; 2.8) <0.01 1.8 (0.8; 4.0) 0.18
No Ref Ref 
a The values in the models are adjusted odds ratio (95%CI).  Definitions: AOR, Adjusted odd ratio; 
HEU, HIV exposed uninfected; HUU, HIV unexposed; Ref, Reference category. Only variables that 
had a significant association with low birth weight in the bivariate analysis were included the final 
multivariable models.
b Model included 8202 HIV exposed and unexposed infants. 
c Model included 2414 HIV exposed uninfected infants.
d Except for the asterisk below, the p-values in this table are t test p-values.  The 5% significance 
level was used in all analyses
* This p-value is derived from the joint hypothesis testing adjusted Wald test
Supplementary material
Sampling
580 primary health clinics (PHCs) and community health centres (CHCs) offering 
immunisations services were stratified into 3 strata, within each province, based on their annual 
6 week immunisation coverage: small (<130 annual immunisations); medium (130-300 annual 
immunisations) and large (>300 annual immunisations) facilities. Small facilities were 
excluded from the final sample due to logistical constraints. Using the 2008 national antenatal 
maternal HIV prevalence (29.0%) as a cut-off point, facilities in the large immunisation stratum 
were further stratified to  below or above the national average for antenatal HIV prevalence 
generating a total of 23 strata.  A stratified two-stage sampling approach then followed. In the 
first stage, the primary sampling units (health facilities) were randomly selected proportional 
to the size of each stratum. In the second stage, a fixed number of infants, comprising of the 
median number of infants expected within a stratum in a sampling window of 3-4 weeks, was 
consecutively or randomly selected in each facility. Based on a design effect of 2 and relative 
precisions for MTCT risk of 30-50% across provinces, a target sample size of 12200 was 
estimated to generate valid provincial and national estimates for vertical HIV transmission at 
6 weeks postpartum [1].
Laboratory testing
Infant dried blood spot (iDBS) specimens were collected by trained nurse data collectors and 
sent to the National Institute for Communicable Disease (NICD), National Health Laboratory 
Services (NHLS) for HIV antibody serology testing and, for antibody positive samples, testing 
for both HIV-1 proviral DNA and HIV-1 RNA using an enzyme immunoassay (EIA) 
[Genscreen HIV1/2 Ab EIA Version2, Bio-rad Laboratories, France]. Antibody positive 
specimens collected at the 6week study visit, which underwent a second confirmatory test 
[Vironostika HIV Uni-form II plus O, bioMérieux Clinical Diagnostics, Marcy-L’Etoile, 
France], were tested for both HIV-1 proviral DNA and HIV-1 RNA using a qualitative 
Polymerase Chain Reaction (PCR) COBAS AmpliPrep/COBAS TaqMan (CAP/CTM) 
Qualitative assay version 1.0, Roche Diagnostics, Branchburg, NJ] to determine infection 
status. Ten percent of antibody negative tests were re-tested to confirm negativity. 
Construction of socio economic status variable
Given that our asset variables were discrete we used multiple correspondence analysis (MCA) 
rather than the principal components analysis (PCA) method [2], which is better suited for 
normally distributed continuous variables, to construct our socio-economic index [3] using 
binary variables on household asset ownership (television, refrigerator, stove, phone and car), 
facilities (access to piped water, electricity and flush toilet) and housing characteristics (brick 
or non-brick structure).These variables were checked for internal consistency (Cronbach’s 
alpha=0.73). Using index scores from the first dimension, which explained 84.5% of the 
variation, we classified households into quintiles: quintile one representing the poorest 
households and five the least poor. The reliability of the final index was assessed by checking 
the distribution of certain variables (access to a refrigerator, stove, television, telephone, car, 
flush toilet and electricity, housing type and mother’s employment status) across the quintiles 
[4].
Handling of missing data 
Twenty nine percent of the study participants did not have gestational age information largely 
because the data were not recorded in their RtHB. As a complete case analysis may introduce 
bias, we used the inverse probability weighting method to account for the missing gestational 
age data in the preterm delivery (PTD) and small for gestational age (SGA) analyses. First we 
generated a predictive logistic regression model for the probability that an individual is missing 
the binary outcome variable, preterm delivery. The following “fully observed”[5] factors were 
considered in the model: maternal education and HIV status, child gender and race, household 
socioeconomic status and an indicator variable for presence of a road-to-health booklet. The 
goodness-of-fit of the model was then assessed using the Hosmer Lemeshow test [6]. The final 
weight for the PTD and SGA analyses was estimated as a product of the survey weight and the 
inverse probability that an individual has missing data for PTD. Only the survey weight was 
applied to the low birth weight (LBW) and underweight-for-age (UFA) analyses. 












































































































































































































































































































































Supplementary table 1: Prevalence estimates
Outcome Numerator Denominator 
PTD Number of infants with gestational age<37 
weeks
Number of infants with gestational 
age data
LBW Number of infants with birth weight 
<2.5Kg
Number of infants with birth weight 
data
SGA Number of infants with small for 
gestational age Z-score <-1.28
Number of infants with small for 
gestational age Z-score data
UFA Number of infants with weight-for-age Z-
score <-2
Number of infants with weight-for-
age Z-score data
Note: Weights were applied to all prevalence estimates. Definitions: low birthweight; LBW, preterm 
delivery; PTD, small-for-gestational age; SGA, underweight-for-age; UFA, 
Supplementary table 2: Studies comparing birth outcomes in HIV exposed and unexposed 
African infants
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Abbreviations: ABC; Abacavir, ARV; antiretroviral,  ART: antiretroviral treatment, EFV; Efavirenz,
HEU; HIV exposed uninfected, HUU; HIV unexposed, LPV/r; Lopinavir/Ritonavir, low birthweight; 
LBW, preterm delivery; PTD, small-for-gestational age; SGA, NVP; Nevirapine, ZDV; Zidovudine, 
underweight-for-age; UFA
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